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ABSTRACT 
 
Implantation, a critical early event during pregnancy, is a three stage process. It starts with 
apposition and adhesion of the blastocyst to a receptive uterine epithelium which is then 
followed by invasion of the blastocyst into a decidualizing stroma. These stages are tightly 
regulated by steroid hormones Estrogen (E) and Progesterone (P). Genomic profiling in mice has 
uncovered novel steroid regulated genes in the uterine luminal epithelium and also in the stroma 
which regulate implantation. Recent evidence also points to the fact that stromal-epithelial 
interactions are critical for a successful implantation. To understand the mechanisms governing 
these complex interactions and better address the clinical challenges to infertility, it is important 
to integrate the information gained from these studies. Chapter I presents a detailed analysis of 
the knowledge gained from reviewing these studies. 
 Estrogen acts via its cognate steroid hormone receptor, estrogen receptor alpha (ESR), 
in order to exert its effects during pregnancy. The studies reported here investigate E’s action via 
ESR1 and its downstream targets in uterine physiology and is written in three parts. The first part 
is an investigation of role of epithelial ESR1in the uterus during stromal cell decidualization. 
Earlier studies in our lab had indicated an essential role of uterine ESR1 in stromal cell 
decidualization. This study prompted an investigation into the compartment specific role of 
ESR1 in uterine stromal cell decidualization. We have used an epithelial specific knockout 
mouse of Esr1 known as WE
d/d 
in order to analyse the role of epithelial ESR1 in this process.  
Our investigation has provided novel insights into a paracrine mechanism of action in which 
Epithelial ESR1 controls stromal cell decidualization via Leukaemia Inhibitory Factor (LIF) and 
Indian Hedgehog (IHH). 
 The second part of this study investigates the role of signal transducer and activator of 
transcription 3 (STAT3) in the uterine epithelial cells during implantation. STAT3 is activated 
downstream of LIF, an E target gene, in the uterine epithelial cells during the window of 
implantation. To identify the molecular pathways regulated by STAT3, we created SW
d/d
 mice in 
which Stat3 gene is conditionally inactivated in uterine epithelium. These mutant mice are 
infertile and exhibit embryo implantation and uterine stromal cell decidualization defect. Further 
analysis revealed dysregulation of several junctional complexes in the luminal epithelial cells of 
SW
d/d 
mice during the window of implantation which adversely affects uterine receptivity and 
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embryo attachment. Additionally, epithelial STAT3 also controlled certain aspects of stromal 
cell decidualization by inducing the expression of epidermal growth factor (EGF) production in 
the luminal epithelium during implantation. A decrease in EGF production adversely affects 
stromal cell proliferation. Our results uncovered an intricate genetic network operating 
downstream of STAT3 that regulates uterine epithelial junctional reorganization, stromal 
proliferation and differentiation, which are critical determinants of successful implantation.  
 In the fourth chapter of this thesis we describe our ongoing studies investigating the 
role of an E target gene, endothelial PAS domain – 1 in uterine decidual angiogenesis. Our 
laboratory has shown that it is local E production acting via ESR1 within the uterine stromal 
cells that drives and sustains the decidualization response. Furthermore this local E production 
regulates EPAS-1, also called hypoxia-inducible factor 2 alpha (Hif2).  EPAS-1 is a 
transcription factor that has been shown to be regulated by hypoxic conditions and regulates 
molecules essential for an angiogenesis response. In order to study the functional role of EPAS-
1we have created a conditional knockout of the EPAS-1, which has EPAS-1 knocked out in all 
cells expressing PGR. This conditional knockout mouse, termed Epas-1
d/d
, is infertile. Further 
analysis revealed that without EPAS-1in the stromal cells, angiogenesis at the early stages of 
pregnancy is impaired as marked by a downregulation of an endothelial cell marker, PECAM. 
Understanding downstream molecules of EPAS-1will undoubtedly give insight into the 
molecular pathways essential for uterine decidual angiogenesis.  
 
 
 
  
iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my parents Anil Pawar and Annie Pawar
v 
 
ACKNOWLEDGMENTS 
 
I would like to thank my advisor, Dr. Milan Bagchi, for his continued support and 
encouragement. Dr. Bagchi has helped me tremendously in structuring my research and guiding 
me in the development of my projects. I would also like to thank Dr. Indrani Bagchi who has 
fulfilled an advisory role during my Ph.D. studies. Indrani has critiqued my research and 
challenged my ideas. This continued input has been essential in developing my research projects. 
Both Milan and Indrani have guided me during my development into a confident research 
scientist. I will always be grateful for their mentorship and support. 
I would also like to thank my other committee members Dr. Benita Katzenellenbogen, 
Dr. Lori Raetzman and Dr. Eric Bolton whose comments and critiques of my research have been 
greatly appreciated. I also thank them for their continued advice and support during my search 
for potential post-doctoral research positions.  
I give a very special thank you to Ms Elizabeth Hunt, who has helped me a great deal in 
performing a variety of mouse surgeries and was always there when I needed help with mouse 
work. My PhD studies would have taken a significantly longer time if I would have not received 
help from her. I would like to give special thanks to Dr. Mary Jo Laws who has taught me a lot 
about how good research is done and many a times has been a soundboard for all my cribbing’s. 
I would like to thank my current members Dr. Yuechao Zhao, Janelle Mapes and Alison Hantak, 
as well as past lab members Dr. Elina Starostvetsky, Dr. Cyril Ramathal and Dr. Lavanya 
Anandan for their helpful critiques of my work. 
I would like to express my appreciation to the Reproductive Biology group here at the 
University of Illinois. I feel fortunate to have worked in an environment that has experts in areas 
of Reproductive Biology. There are so many great Faculty members in the Reproductive Biology 
group that are invested in the success of graduate students and post-doctorate fellows.  This is 
one reason why studying Reproductive Biology at UIUC has been so exceptional. Additionally, I 
would like to give a very large thank you to Karen Doty, the histologist at the Center for 
Reproduction and Infertility. She has contributed greatly to the all my work.  
Last but not the least I thank my family and friends.  My parents, Anil Pawar and Annie 
Pawar, their faith in me and my abilities is what keeps me going. My eldest sister, Sulabha, who 
is my best friend, my mentor and my backup mother. Without her love and guidance I would not 
be the person I am today. My elder sister Smita, who makes me feel I am the best at everything. 
vi 
 
My fiance Niyati, she is truly my rock. She has been with me through thick and thin and her 
unwavering love and support has helped me immensely in accomplishing my goals. Also, special 
thanks goes out to my roommates and gym buddies, Vineet Abhishek, Ritoban Basu Thakur, 
Nachiketa Chakraborty, Vineeth Madhavan, and Amandeep Gargi who helped me adjust to a 
new life in US and made life interesting at UIUC these past five years. In the end, I would like to 
thank Ms Lesa Scharnett, a group fitness instructor in CRCE because of whom I found another 
passion in my life and am as fit as I can be mentally and physically today. 
 
vii 
 
Table of Contents 
 
CHAPTER I: Steroid-Regulated Molecular Pathways Controlling Implantation ...........................1 
 
CHAPTER II: Role of Epithelial Estrogen Receptor Alpha in Stromal Cell Decidualization ......23  
 
CHAPTER III: Role of Signal Transducer And Activator Of Transcription 3 during      
Implantation ...................................................................................................................................61 
 
CHAPTER IV: Ongoing/Future Studies - Role of Endothelial PAS domain protein-1 (EPAS-1) 
in Uterine Decidual Angiogenesis ...............................................................................................105 
 
CHAPTER V: Conclusion ...........................................................................................................124 
 
 
 
1 
 
 
 
 
 
 
CHAPTER I 
 
 
Steroid-Regulated Molecular Pathways Controlling Implantation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
Introduction 
 In mammals, the principal function of the uterus is to support the growth and 
development of the fetus during pregnancy. During establishment of pregnancy, the embryo 
comes into intimate physical contact with the uterine endometrium and implants into this 
tissue [1-3]. Successful implantation requires attachment of the embryo to the uterine luminal 
epithelium and its subsequent invasion into the underlying stromal bed [4]. Embryo invasion 
triggers a unique transformation of the stromal cells, known as decidualization, which 
involves sequential proliferation and differentiation of these cells [5,6]. The differentiated 
stromal tissue supports uterine remodeling and development of an elaborate maternal 
vasculature that plays a critical role in embryonic growth and survival [7,8]. The events 
during early pregnancy are profoundly influenced by the ovarian steroid hormones, 17β-
estradiol (E) and progesterone (P). The molecular mechanisms via which steroid-regulated 
pathways control these processes are under intense investigation by many laboratories around 
the world.  
 In humans, infertility is one of the most common disturbances of reproductive 
health. Despite significant advances in assisted reproductive technologies (ART), many 
couples experience infertility as a result of failed implantation of the fertilized embryos into 
the uterus and subsequent loss of pregnancy. The implantation rates in ART remain low, even 
with high-quality embryos, emphasizing the importance of this process as a major cause of 
pregnancy failure and infertility [9]. Understanding the signaling mechanisms central to 
implantation has the potential to alleviate many problems associated with infertility and 
improving the outcome of ART. Because of ethical considerations, research to study the early 
events during human pregnancy is restricted. However, the mouse has served as an important 
animal model to investigate the molecular mechanisms underlying female infertility [10]. 
This review will focus on our emerging understanding of the network of steroid hormone-
regulated molecular pathways that regulate endometrial function during implantation in the 
mouse. 
 During early pregnancy, E and P act in an opposing fashion to orchestrate changes 
in the uterine epithelium that render it competent for embryo attachment. In mice, 
preovulatory ovarian E stimulates uterine epithelial growth and proliferation on days 1 and 2 
of pregnancy [11-13]. In the E-dominated proliferative phase, the epithelium displays a 
distinct columnar phenotype and expresses proteins, such as E-cadherin, which play a key 
role in the maintenance of the adhesive and polarized phenotype of uterine epithelial cells 
[14,15]. Starting on day 3 of pregnancy, in response to rising P levels, epithelial cells cease to 
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proliferate and enter a differentiation program. On day 4 of pregnancy, uterine epithelial cells 
lose their polarity, as indicated by the downregulation of E-cadherin from junctional 
complexes, and acquire adhesiveness for the embryo [16]. The attachment of the embryo to 
the uterine epithelium is followed by the P-driven differentiation of subjacent fibroblastic 
stromal cells into secretory decidual cells. Thus, critical uterine changes during implantation 
are orchestrated by an intricate interplay of E and P signaling via their cognate receptors 
[1,2]. Recent studies have revealed that a series of molecular communications between the 
epithelial and stromal cells, guided by the steroid hormone receptors present in these tissues, 
is critical for acquisition of uterine receptivity and progressive functional interactions with 
the embryo [17-19]. Here we will summarize our emerging understanding of the mechanisms 
that mediate this cell-cell dialogue. 
 
ESR1 and PGR control implantation  
 The cellular actions of E and P are mediated through their intracellular receptors, 
estrogen receptor alpha (ESR1) and progesterone receptor (PGR), respectively. These 
receptors function as ligand-inducible transcription factors [20]. Ligand-occupied ESR1 and 
PGR bind to specific genomic sites to activate or repress the expression of their target genes. 
Use of chromatin immunoprecipitation coupled to high throughput sequencing (ChIP-Seq) 
has identified genome-wide binding sites of ESR1 and PGR [21,22]. These receptors can also 
control target gene transcription by tethering to other transcription factors bound to the gene 
regulatory regions. Recent studies indicate that binding of these receptors can occur at distal 
enhancer regions, which then form complexes with the proximal promoter through a 
chromosomal looping event [23,24]. 
 A large body of literature indicates that E and P, acting through their receptors, 
regulate cell proliferation, differentiation and secretory protein production in the uterus 
[25,26]. Accordingly, a dynamic pattern of expression of ESR1 and PGR proteins is seen in 
both epithelial and stromal compartments of the uterus during the reproductive cycle and 
pregnancy. A global knockout of Esr1 established a critical role of this receptor in the 
regulation of overall uterine function, particularly in E-induced growth of this tissue [27,28]. 
Global knockout of Pgr established that P signaling via its receptor is essential for 
decidualization, and is a prerequisite to successful implantation [29]. Although these mouse 
models underscored the central importance of proper steroid hormone signaling during 
pregnancy establishment, they exhibit pleiotropic defects. Furthermore, they cannot inform us 
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of the stromal or epithelial compartment-specific roles of these hormone receptors since the 
receptors are ablated from all uterine cells. 
 
Tissue recombination studies: initial evidence for epithelial-stromal crosstalk 
In a series of elegant studies, Cunha et al used uterine tissue recombinants obtained 
from Esr1-null and Pgr-null mice to dissect individual roles of epithelial and stromal steroid 
receptors in regulating uterine proliferation and differentiation [30]. To examine the role of 
ESR1 in E-induced epithelial proliferation, tissue recombinants were prepared, using 
epithelium and stroma from wild-type (WT) and Esr1-null mice [31]. This study reported that 
the mitogenic effect of E in uterine epithelium is independent of epithelial ESR1, but is 
dependent on stromal ESR1. This surprising result suggested that uterine epithelial 
proliferation is a paracrine event dictated by E signaling originating in the stromal 
compartment. With a similar approach using Pgr-null mice, Cunha’ group went on to 
demonstrate that stromal PGR is both necessary and sufficient to mediate the anti-
proliferative effects of P on E-induced epithelial cell proliferation [32]. Collectively, Cunha’s 
experiments suggested that uterine epithelial cell proliferation is controlled by stromal ESR1 
and its antagonism is mediated by stromal PGR, indicating that E or P acting on uterine 
stromal cells initiate paracrine mechanisms that modulate epithelial proliferation.  However, 
since these studies used neonatal mouse tissue, questions were raised whether these results 
truly reflect adult uterine physiology. Nevertheless, these studies underscored, for the first 
time, the importance of stromal-epithelial communications in regulating key uterine 
functions.  
 
Conditional deletion of Esr1 and Pgr in the uterus 
The advent of the Cre-Lox strategy for generating tissue-specific gene deletion has 
allowed researchers to make great advances in understanding the cell-type-specific roles of 
ESR1 and PGR in the adult mouse uterus. Recently, Korach’s group has addressed the 
epithelial cell-specific role of ESR1 by using the WNT7A-Cre mouse model, which allows 
ablation of the Esr1 gene specifically in luminal and glandular epithelia [33]. They reported 
that the epithelial ESR1 does not control E-mediated epithelial cell proliferation, raising the 
possibility that stromal ESR1 actually regulates epithelial growth via paracrine mechanisms. 
This observation is in excellent agreement with Cunha’s tissue recombination studies [31]. 
Korach’s group showed further that ESR1 induces the expression of insulin-like growth 
factor-1 (IGF-1) in the stromal cells [34]. Since IGF-1 receptor is abundantly expressed on 
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the luminal and glandular epithelium, this finding is consistent with the view that IGF-1 is a 
paracrine factor of stromal origin mediating E-driven uterine growth [35]. It is pertinent to 
mention here that our recent findings support a role of stroma-derived growth factors, 
although distinct from IGF-1, in mediating E-induced epithelial proliferation [36]. So, it is 
conceivable that multiple E-regulated signals of stromal origin might be involved in uterine 
epithelial growth.   
Compartment-specific conditional knockout mice have also proved valuable in 
delineating the role of PGR in epithelial-stromal crosstalk. DeMayo’s group generated and 
characterized a uterine epithelial-specific knockout of Pgr [37]. These knockout mice are 
infertile due to defects in embryo attachment, stromal cell decidualization, and the inability to 
suppress E-induced epithelial cell proliferation.  The findings of this study suggested that 
epithelial PGR is a critical regulator of epithelial receptivity. It also mediates P regulation of 
E-induced epithelial proliferation, although no mechanism for this has been proposed.  
Importantly, previous studies by this group showed that P regulates the production of the 
morphogen Indian Hedgehog (IHH) by the luminal epithelium, which then acts on the 
stromal cells to promote decidualization.  Taken together, these studies highlight the critical 
role of epithelial PGR in regulating stromal cell decidualization via a paracrine mechanism. 
 
Downstream Mediators of E and P Function during Implantation 
Extensive use of gene expression profiling has uncovered many genes that are 
regulated by E and P during implantation [38-40]. During the past several years, with the 
advent and continued refinement of gene knockout and knock-in strategies, transgenic mice 
have become powerful tools for determining the functional roles of several of these E- and P-
regulated pathways in various aspects of uterine physiology [41,42]. Studies employing these 
animal models have established that these factors critically regulate uterine growth and 
differentiation, which in turn control embryo-endometrial interactions during early 
pregnancy. Here we provide a brief description of the physiological relevance of these 
steroid-regulated genes in the context of epithelial-stromal interactions during implantation 
and decidualization. 
 
Steroid-induced epithelial-stromal crosstalk involving glandular epithelium, luminal 
epithelium and stroma: role of LIF, STAT3 and the EGF family 
The leukemia inhibitory factor (LIF), produced by the endometrial glands during 
implantation, plays a central role in a crosstalk involving three different uterine cell-types. It 
6 
 
was discovered as an obligatory factor for implantation by Stewart’s group in 1992 [43]. LIF, 
a member of the interleukin-6 (IL-6) family, functions through the LIF receptor, which is 
associated with the signal transducer GP130 [44]. In the uterus, its expression is induced 
specifically in the glandular epithelium in response to a transient surge of E immediately 
prior to implantation [45]. LIF receptors are primarily located in the luminal epithelium at the 
time of implantation. Our recent studies indicated that the conditional ablation of epithelial 
Esr1 leads to a loss of LIF production by the glands, confirming the E regulation of this 
factor (Sandeep Pawar, Indrani C. Bagchi, and Milan K. Bagchi, unpublished results). 
However, it is unclear whether ESR1 directly controls LIF expression in this tissue.  
In female mice lacking LIF, the embryos fail to attach to the luminal epithelium due 
to a defect in uterine receptivity [43]. It was reported that, during implantation, LIF, secreted 
from the glands, binds to its receptors in luminal epithelial cells and activates the JAK-
STAT3 pathway, as described in Figure 1. To understand the molecular mechanisms via 
which the LIF-STAT3 signaling pathway controls uterine functions during implantation, 
Pawar et al created a mutant mouse model in which Stat3 is specifically deleted in the uterine 
epithelium, but is retained in the stroma [46]. Using this mouse model, it was revealed that 
STAT3, upon activation following LIF signaling, alters the molecular organization of 
epithelial junctional complexes at the time of implantation. STAT3 suppresses the expression 
of the tight junction proteins claudin-1, -3 and -4 within the implantation window. It also 
down regulates the expression of α and β-catenin, which likely contributes to the 
redistribution of E-cadherin away from the lateral adherent junctional complexes during 
implantation. The concerted downregulation of the tight and adherent junction complexes in 
the luminal epithelium, driven by STAT3 signaling, critically alters the uterine epithelial 
phenotype by disrupting cell-cell linkages and triggering a loss of epithelial polarization. This 
presumably leads to proper organization and presentation of cell surface adhesion molecules 
that allow interaction with the blastocyst trophectoderm initiating the process of implantation.  
Pawar et al also reported that the conditional loss of uterine epithelial STAT3 results in 
impaired decidualization [46]. Specifically, it was noted that, in the absence of uterine 
epithelial STAT3, the stromal cells exhibit a significantly reduced capacity to undergo 
proliferation in response to a decidual stimulus. These results suggested a role of epithelial 
STAT3 in promoting production and/or secretion of a paracrine factor(s) from the uterine 
epithelium, which in turn induces stromal cell proliferation, as depicted in Figure 1.1. Indeed, 
a marked reduction in the levels of a subset of EGF family growth factors was observed in 
the Stat3-null uterine epithelium in the period following implantation, indicating that these 
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growth factors are likely downstream paracrine effectors generated by epithelial STAT3 
signaling. Consistent with this hypothesis, a marked reduction in the level of active, 
phosphorylated EGFR was observed in the uterine stroma of these mutant mice. Furthermore, 
administration of exogenous EGF family factors was effective in rescuing the uterine stromal 
proliferation defect in mice lacking uterine epithelial STAT3.    
Recent studies by two other groups have also indicated a role for uterine stromal 
STAT3 in controlling the decidualization process [47,48].  They used conditional mutant 
mice, developed by crossing floxed Stat3 mice with Pgr-Cre mice, which resulted in Stat3 
gene deletion in both epithelial and stromal compartments of the uterus.  Loss of uterine 
STAT3 led to alterations in pathways in the stromal cells with consequent dysregulation of E 
and P signaling in the uterus as reported by these investigators. Collectively, these studies 
provided valuable insights into the mechanisms by which LIF-STAT3 signaling allows 
transition of uterine epithelium and stroma to proper functional states that permit embryo 
attachment, invasion and the subsequent decidualization of the underlying stroma. 
 
Steroid-induced epithelial-stromal crosstalk originating in the epithelium: role of the 
IHH-COUP-TFII pathway 
Indian Hedgehog (Ihh) represents a prototype hormone-regulated paracrine factor that 
links epithelial and stromal functions in the uterus. It is a member of the Hedgehog family of 
morphogens that is induced by P in the uterus [49]. Recent studies by the DeMayo group, 
using ChIP-Seq, showed that PGR binds directly to the Ihh promoter [22]. In the 
endometrium, Ihh is expressed in the luminal and glandular epithelium prior to implantation 
and its expression decreases thereafter [49]. Its receptor Patched-1 (PTCH-1) is also up 
regulated in a similar temporal fashion in the luminal epithelium and stroma. To study IHH-
mediated signaling in the uterus, Lee et al created a conditionally deleted mutant of Ihh using 
Pgr-Cre mice [50]. The resulting mutant females are infertile, exhibiting implantation defects 
and failure to respond to an artificial decidual stimulus. Defects in implantation were 
attributed to sustained ESR1 activity in mutant mice [51]. Loss of IHH also resulted in 
reduced expression of PTCH-1 and the transcription factor COUP-TFII (Chicken Ovalbumin 
Upstream Promoter-Transcription Factor II, also known as NR2F2) in the subepithelial 
stroma [50]. Taken together, these observations suggested that IHH is a major effector of 
PGR signaling in the uterus. When secreted from the luminal epithelium, it influences 
stromal function by regulating COUP-TFII, as shown in Figure 1.2, and thereby mediates the 
communication between the uterine epithelium and stroma required for embryo implantation. 
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COUP-TFII, which is expressed almost exclusively in the uterine stroma, acts 
downstream of IHH [50]. To assess its uterine function, a conditional COUP-TFII knockout 
mouse was generated using Pgr-Cre mice. Similar to Ihh-null mice, COUP-TFII-null females 
are infertile due to an implantation failure [52,53]. It was demonstrated that COUP-TFII-null 
mice exhibit enhanced E activity in the epithelium during the implantation window, which 
inhibits epithelial maturation and thus leads to failure of embryo attachment. It was also 
reported that COUP-TFII regulates PGR expression in the uterine stroma [52]. Stromal PGR, 
acting through paracrine mechanisms, down regulates ESR1 activity in the luminal 
epithelium to promote a receptive uterus. So, suppression of stromal PGR in COUP-TFII-null 
mice may result in dysregulated E signaling in the epithelium. Interestingly, COUP-TFII-null 
mice also failed to undergo experimentally induced decidualization, a defect linked to 
decreased expression of bone morphogenetic protein 2 (BMP2), a factor induced in the 
uterine stroma in response to P stimulation [54].  Previous studies in our laboratory and the 
DeMayo laboratory have shown that WNT4 acts downstream of PGR and BMP2 to regulate 
stromal decidualization [55,56]. Taken together, the Ihh-null and COUP-TFII-null mice 
demonstrated that the IHH-COUP-TFII signaling pathway functionally link the epithelial and 
stromal compartments, as indicated in Figure 2, and is essential for successful implantation. 
 
Steroid-induced epithelial-stromal crosstalk originating in the stroma: regulation by 
HAND2 and FGFs 
Although the tissue recombination studies of Cunha’ group indicated that stromal 
PGR plays a pivotal role in mediating the antiproliferative effects of P on the uterine 
epithelium, the molecular mechanisms by which P achieves this regulation remained unclear 
until recently. Microarray-based profiling of P-responsive transcripts during the implantation 
window in the mouse identified the basic helix-loop-helix transcription factor heart and 
neural crest derivatives-expressed protein 2 (Hand2) as a P-regulated gene in the uterine 
stroma [36,57]. HAND2 is robustly expressed in the uterine stroma by day 3 of gestation but 
is notably absent in the epithelium. Its stromal expression persists through the peri-
implantation phase and is detectable until day 8.5 of pregnancy [58]. Recent genome-wide 
PGR binding studies indicated that Hand2 is a direct target of regulation by this receptor [22].  
A study by Li et al revealed that HAND2 plays a central role in controlling the 
paracrine mechanisms that mediate the antiproliferative effects of P in the endometrium 
[36,59]. Deletion of Hand2 in the mouse uterus, using Pgr-Cre, resulted in infertility due to 
failed implantation.  Hand2-null mice showed persistent luminal epithelial proliferation on 
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day 4 of pregnancy, indicating that, in the absence of HAND2, pregnant
 
uteri fail to achieve a 
receptive state. HAND2 was shown to regulate the expression of a subset of stromal 
fibroblast growth factors (FGFs). Unopposed, stromal FGFs, presumably induced by E via 
stromal ESR1, act in a paracrine fashion to target receptors on the luminal epithelium and 
mediate epithelial proliferation through ERK1/2 activation.  HAND2 mediates the anti-
proliferative effects of P by inhibiting the production of FGFs, and thus terminating E-driven 
epithelial proliferation, as illustrated in Figure 1.3. Additionally, phosphorylation and 
activation of epithelial ESR1 was also shown to be persistent in Hand2-null
 
mice.  Together, 
these findings show that loss of HAND2 removes the brake by which the uterus shifts from a 
proliferative state to a differentiated state and creates a tissue unreceptive to the blastocyst.  
This study provides a plausible mechanism by which epithelial proliferation is controlled in a 
paracrine manner by signaling molecules produced downstream of steroid action in the 
stroma. 
 
Dysfunction of stromal-epithelial crosstalk leads to reproductive diseases 
During the past several years, the use of conditional knockout mice has allowed us to 
make great strides in identifying key molecular players important for the implantation 
process. Many of these factors, of both stromal and epithelial origin, have been well 
characterized in vitro and in vivo.  An emerging concept is that dysregulation of these factors 
not only affects fertility, but is also linked to other reproductive pathologies, such as 
endometriosis and endometrial cancer. Endometriosis, a chronic disease characterized by 
endometrial epithelium and stroma implanting outside of the uterus, is often associated with 
inflammation, abdominal pain, and infertility [60,61]. Because endometriotic tissue exhibits 
deregulation in differentiation gene networks associated with PGR signaling, endometriosis is 
often considered a P resistant disease, although the mechanism is not fully understood [62]. 
In addition, several lines of evidence link endometriosis with elevated expression of P450 
aromatase and consequent increase in 17-estradiol (E) signaling in the endometriotic tissue 
[61].  
Bulun’s group has shown that specific steroid hormone receptor isoforms are 
differentially regulated in stromal cells isolated from normal and endometriotic tissue [63]. 
For example, the PGR-B isoform, but not PGR-A, is downregulated in endometriotic stroma 
[64]. It was proposed that the stromal dysregulation of PGR contributes to endometriosis 
through the downregulation of 17-hydroxysteroid dehydrogenase type 2 (HSD172), an 
enzyme that metabolizes E into estrone, a weakly estrogenic metabolite [65]. This impaired E 
10 
 
metabolism, coupled with the abnormal high expression of P450 aromatase that is seen in 
endometriotic tissue, leads to excessive local E signaling, which presumably drives the 
growth of endometriotic lesions. Additional studies have linked impaired expression of other 
key P-regulated pathways in the stroma to the pathogenesis of endometriosis [66-68]. Bulun’s 
group has also reported that the level of ESR2 expression is significantly greater in 
endometriotic stroma versus normal [69]. They postulated that the increased ESR2 levels 
observed in endometriosis are a consequence of hypomethylation at a CpG island within the 
Esr2 promoter, and that ESR2 overexpression leads to the observed suppression of ESR1 and 
PGR. Taken together, these reports support the concept that aberrant steroid receptor 
expression in endometriosis, likely driven by epigenetic alterations, results in dysregulation 
of paracrine signaling between the stroma and the epithelium, leading to abnormal epithelial 
proliferation and stromal differentiation observed in this disease.  
Recent studies revealed that impaired stromal-epithelial interactions may also 
contribute to endometrial hyperplasia, a precursor to endometrial cancer, which is associated 
with unregulated E signaling [68]. Treatment regimens for this condition often include 
progestin therapy to inhibit E mediated proliferation. Jones et al. identified HAND2 as the 
most commonly hypermethylated and silenced gene in endometrial hyperplasia and cancer 
[70]. The degree of HAND2 methylation was positively correlated with the severity of 
hyperplasia.  It was further shown that uterine samples from patients that did not respond to 
progestin treatment exhibited greater HAND2 methylation than positive responders. 
Morphological changes similar to complex atypical hyperplasia were also observed in uteri of 
aged Hand2-null mice as seen in Figure 1.4, including increased gland to stroma ratio and 
irregularities in glandular shape, compared to age matched control mice.  Loss of Hand2 also 
results in down-regulation of the tumor suppressor Pten, an event that often occurs early 
during endometrial carcinogenesis [68]. Collectively, these results indicated that stromal 
epigenetic modifications of key target genes, such as HAND2, have a profound effect on the 
protective effects of P on the epithelium and can now be considered as predictors of progestin 
responsiveness in endometrial cancer treatment regimens. 
 
Conclusion 
Steroid hormones, acting through their cognate nuclear receptors, regulate various 
aspects of uterine physiology and pregnancy.  In preparation for implantation, these 
hormones orchestrate the cellular events in different uterine compartments to achieve 
blastocyst attachment to the luminal epithelium and subsequent invasion into the stroma. A 
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defect in any of these steps may cause infertility. This review has highlighted several key 
steroid-regulated pathways that play an important role in epithelial-stromal crosstalk during 
early pregnancy. Tissue-specific gene knockout mouse models combined with powerful 
bioinformatic approaches have helped us understand how these pathways act in different 
uterine compartments to synchronize the critical events to achieve successful implantation. 
We have also described briefly the emerging studies that suggest that epigenetic alterations at 
specific gene loci impact on uterine functions, leading to reproductive disorders and cancer.  
These novel and important insights, along with future studies, will help develop new 
therapeutic approaches in treating infertility and other reproductive disorders arising from 
aberrant steroid hormone signaling in the uterus.    
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Figure 1.1 Steroid-mediated glandular epithelium-luminal epithelium-stromal crosstalk 
in the uterus. E induces LIF in the glandular epithelium (blue), which acts in a paracrine 
manner on the luminal epithelium (purple) to activate the JAK/STAT pathway to mediate a 
shift in junctional integrity required for implantation.  Activation of JAK/STAT also 
promotes proliferation of the stroma (pink) via expression and secretion of EGF family 
proteins from the luminal epithelium.  Dashed lines represent indirect events.  E, estrogen; 
ESR1, E receptor;  LIF, leukemia inhibitory factor; LIFR, LIF receptor; JAK/STAT3, Janus 
kinase/signal transducers and activators of transcription 3; EGF, epidermal growth factor; 
EGFR, EGF receptor.   
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Figure 1.2 Steroid-mediated luminal epithelium-stromal crosstalk in the uterus. P drives 
IHH expression in the luminal epithelium (purple).  IHH acts on the stroma to promote 
decidualization through activation of COUP-TFII signaling.  Decidualization results in 
morphologically distinct stroma (green) compared to undifferentiated stroma (pale pink).  
Dashed lines represent indirect events.  P, progesterone; PR, P receptor; IHH, Indian 
hedgehog; PTCH1, patched 1; COUP-TFII, chicken ovalbumin upstream promoter-
transcription factor II; BMP2, bone morphogenetic protein; WNT4, wingless-type MMTV 
integration site family, member 4. 
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Figure 1.3 Steroid-mediated stromal-epithelial crosstalk in the uterus. Prior to 
implantation, E, acting through ESR1 in the stroma (pink), drives epithelial (purple) 
proliferation through the secretion of paracrine acting FGFs.  During the periimplantation 
period, P, acting on PGR in the stroma, promotes the expression of HAND2.  HAND2 
inhibits expression of FGFs and blocks E-induced epithelial proliferation.  Dashed lines 
represent indirect events.  E, estrogen; ESR1, E receptor; FGF, fibroblast growth factor; 
FGFR, FGF receptor; ERK1/2, extracellular signal regulated kinase1/2;  P, progesterone; 
PGR, P receptor; HAND2,  heart and neural crest derivatives expressed 2. 
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Figure 1.4 Epigenetic silencing of HAND2 through hormonal dysregulation or 
environmental insults leads to signs of complex atypical uterine hyperplasia. 
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ABSTRACT 
Differentiation of uterine stromal cells, known as decidualization, is critical for 
embryo implantation. The role of estrogen receptor alpha (ESR1) during this process is 
unclear. Development of a conditional Esr1-null mouse model in our laboratory showed that 
deletion of this gene in both epithelial and stromal compartments of the uterus leads to a 
complete blockade of decidualization, indicating a critical role of uterine ESR1 during this 
process. To further address the compartment-specific uterine function of ESR1, we created 
WE
d/d 
mice in which Esr1 is specifically ablated in the uterine luminal and glandular 
epithelia, but is retained in the stroma. Interestingly, the uteri of WE
d/d
 mice also failed to 
undergo decidualization. The loss of epithelial ESR1 did not affect stromal progesterone 
receptor (PGR) expression, but markedly reduced the production of leukemia inhibitory 
factor (LIF) in the glandular epithelium. Strikingly, administration of exogenous LIF restored 
decidualization in WE
d/d 
mice. We showed that LIF induces the expression of Indian 
hedgehog (Ihh) in the luminal epithelium. IHH then acts on the stromal cells to induce the 
expression of Nr2f2 a transcription factor that promotes decidualization. Further analysis also 
revealed that LIF and P act synergistically to induce Ihh expression in the uterine epithelium 
by activating the mitogen activated protein kinase (MAPK) pathway. Collectively, these 
results functionally link uterine epithelial ESR1 to stromal differentiation via a paracrine 
mechanism involving LIF and IHH.  
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INTRODUCTION 
Steroid hormones estrogen (E) and progesterone (P) play crucial roles during early 
pregnancy. These hormones function via their cognate receptors to coordinate a complex 
series of interactions between the embryo and the receptive uterus to initiate the process of 
implantation (1-3). In mouse and human, one of the prerequisites for successful implantation 
is the differentiation of endometrial stromal cells into a unique secretory tissue, known as the 
decidua. This remarkable transformation event, known as decidualization, comprises 
morphogenetic and biochemical changes driven by the estrogen and progesterone receptors 
leading to successful establishment of pregnancy (4, 5). Decidualization is also accompanied 
by the creation of an extensive vascular network within the stromal bed that supports 
embryonic growth until placentation ensues (6, 7). 
The development of mutant mouse models lacking receptors for progesterone (Pgr) 
and estrogen (Esr) has firmly established the necessity of steroid signaling for implantation. 
The Pgr-null mice display a refractory uterus that fails to respond to an experimentally 
induced deciduogenic stimulus, establishing a central role played by P in regulating the 
decidualization phase of pregnancy (8, 9). In contrast, the estrogen receptor alpha (Esr1)-null 
mice, although impaired in its preparedness for blastocyst attachment, exhibited decidual 
response challenging the essentiality of Esr1 in stromal differentiation during early 
pregnancy (10). It was later revealed that the uteri of these mutant mice expressed a truncated 
ESR1, raising the possibility that it may mediate the decidual response seen in these mice 
(11, 12). Thus, the role of Esr1 in the regulation of decidualization to support establishment 
of pregnancy remained unresolved. 
In the present investigation, we have employed genetic and molecular approaches to 
establish for the first time the critical role of Esr1 signaling in the regulation of endometrial 
stromal cell differentiation. We initially developed conditional knockout mice in which Esr1 
is deleted from both epithelial and stromal compartments of the uterus. Our results revealed 
that these mice displayed a complete blockade of decidualization. To analyze further the 
compartment-specific role of ESR1, we created mice in which Esr1 is specifically ablated in 
the uterine luminal and glandular epithelia, but is retained in the stroma. Interestingly this 
deletion also resulted in a complete blockade of decidualization, indicating that epithelial 
ESR1 controls critical aspects of endometrial stromal cell differentiation. Our studies further 
uncovered a novel paracrine mechanism in which epithelial ESR1 controls stromal cell 
decidualization via LIF and IHH signaling cascades. These findings are of high clinical 
relevance because proper E signaling is critical for implantation and establishment of 
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pregnancy. A deeper understanding of the E mediated signaling in the uterus would help in 
improving in vitro fertilization techniques. 
 
RESULTS  
To investigate the function of ESR1 during decidualization, we created a conditional 
knockout of the Esr1 gene in the uterus of adult mice by employing the Cre-LoxP strategy. 
Transgenic mice expressing Cre under the control of Pgr promoter were used previously to 
ablate “floxed” genes in the uterus (13). We crossed these Pgr-Cre mice with those harboring 
the “floxed” Esr1 gene (Esr1fl/fl) to create the Esr1d/d mice in which the Esr1 gene is deleted 
in uterine cells expressing PGR. The ablation of Esr1 in various compartments of Esr1
d/d 
uteri 
was confirmed by immunohistochemistry (IHC). Uterine sections obtained from Esr1
d/d 
mice 
failed to show any ESR1 protein expression in the luminal epithelium, glandular epithelium, 
and stroma (Fig. 2.1A).  
Esr1
fl/fl
 and Esr1
d/d 
mice were then subjected to experimentally induced 
decidualization in which a mechanical stimulation of the steroid-primed uteri triggers a 
decidual response in the absence of an implanting embryo (14). This artificial stimulus 
mimics the embryonic signal during implantation and sets in motion the decidualization 
program. Examination of the gross anatomy of the stimulated and unstimulated uterine horns 
of Esr1
fl/fl
 and Esr1
d/d 
mice indicated that as expected, the uterine horns of Esr1
fl/fl
 mice 
exhibited a robust decidual response within 72 h after receiving the artificial stimulation (Fig. 
2.1B, upper left panel). In contrast, the Esr1-deficient uteri under identical conditions failed 
to show any decidualization (Fig. 2.1B, upper right panel). When the decidual response was 
assessed by measurement of uterine wet weight gain, the Esr1-deficient uteri exhibited a 
markedly reduced weight gain relative to that seen in the Esr1
fl/fl
 uteri (Fig. 2.1C). 
We further analyzed the decidualization response of Esr1
d/d 
uteri by monitoring the 
expression of alkaline phosphatase (ALP), a classical biomarker of decidualization. As shown 
in Fig. 2.1D panel a, the expression of ALP was prominent in the antimesometrial decidual 
cells of the control Esr1-intact uteri at 72 h following decidual stimulation. In contrast, no 
expression of this decidual marker was seen in the uteri of Esr1
d/d 
mice at a similar time 
point, indicating a complete blockade of stromal cell differentiation in these mice (Fig. 2.1D, 
panel b). While these studies with Esr1
d/d 
mice established the critical role played by ESR1 in 
decidualization, we next performed compartment-specific deletion of Esr1 to gain 
mechanistic insight into the role of ESR1 and its downstream signaling pathway in the 
regulation of stromal differentiation.  
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Uterine epithelial ESR1 is indispensable for stromal cell decidualization 
To ablate ESR1 from uterine epithelium, we crossed Esr1
fl/fl
 mice with transgenic 
mice expressing Cre under the control of an epithelium specific Wnt-7a promoter (13, 14). 
This created the WE
d/d 
mice in which the Esr1 gene is deleted exclusively in the uterine 
glandular and luminal epithelial cells expressing Wnt-7a. The ablation of Esr1 gene in the 
uterine epithelium of WE
d/d 
mice was confirmed when uterine sections obtained from these
 
mice failed to show any ESR1 mRNA (Fig. 2.7A) or protein expression in the luminal and 
glandular epithelium, but the expression in the stroma remained unaltered (Fig. 2.7B compare 
panel a and b).  
A six-month breeding study demonstrated that WE
d/d
 mutant mice are infertile (Table 
1). While Esr1
f/f
 mice exhibited normal litter size and pregnancy rates, the WE
d/d
 females 
failed to become pregnant when mated
 
with wild-type males. Further analysis revealed a 
defect in oviductal function and embryo transport in WE
d/d
 females (data not shown). We then 
subjected Esr1
fl/fl
 and WE
d/d
 mice to experimentally induced decidualization as described 
previously. As expected, the decidual response was pronounced in the uterine horns of 
Esr1
fl/fl
 mice (Fig. 2.2A, upper left panel). However, WE
d/d
 uteri under identical conditions 
failed to show any decidualization (Fig. 2.2A, upper right panel). The WE
d/d
 uteri exhibited a 
markedly reduced wet weight gain relative to that seen in the Esr1
fl/fl
 uteri (Fig. 2.2B). Taken 
together, these data indicate that Esr1 in the uterine epithelium is indispensable for stromal 
cell decidualization. 
During decidualization, the uterine stromal cells initially undergo proliferation for 24 
to 48 h followed by differentiation (15, 16). To further investigate the decidualization defect 
in mice lacking Esr1 in uterine epithelium, we monitored proliferation and differentiation of 
steroid hormone-primed stromal cells in response to a decidual stimulation by using known 
markers of these events. Uteri of Esr1
f/f
 mice exhibited widespread staining for Ki67 in the 
stromal cells within 20 h of receiving the decidual stimulus, clearly indicative of extensive 
stromal cell proliferation (Fig. 2.2C, panels a and c). In contrast, the uterine sections from 
WE
d/d
 mice exhibited significantly reduced Ki67 staining under identical conditions (Fig.2. 
2C, panels b and d). Quantitation of the Ki67 signal revealed a significant reduction in the 
number of Ki67-positive cells in the stromal compartment of the WE
d/d
 uteri (Fig. 2.2D). We 
further investigated the proliferation defect in WE
d/d
 uterine stroma by analyzing the 
expression of factors that control various cell cycle checkpoints, including cyclins, and 
cyclin-dependent kinases (Cdks) (17) . Our results revealed a marked down regulation of 
cyclin E1 (Ccne1) and E2 (Ccne2), their corresponding Cdk, Cdk2, and cyclin D1 (Ccnd1) in 
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stromal cells of WE
d/d
 uteri within 20 h of receiving the decidual stimulus (Fig. 2.2E), 
indicating a defect in stromal cell proliferation in uteri lacking epithelial ESR1. 
We next investigated whether stromal differentiation is impaired as a consequence of 
a defect in stromal proliferation. We observed prominent expression of ALP in the decidual 
cells of the Esr1
f/f
 uteri at 72 h after decidual stimulation. However, no expression of this 
decidual marker was seen in the uteri of WE
d/d
 mice at a similar time point, indicating a 
complete blockade of stromal cell differentiation in these mice (Fig. 2.2F, compare panel a 
and b). Collectively, these results indicate that ESR1 in the uterine epithelium is a critical 
regulator of stromal cell proliferation and differentiation during early pregnancy.  
 
Epithelial ESR1 controls decidualization of stromal cells via LIF 
To gain insights into the underlying mechanism by which epithelial ESR1 controls 
differentiation of stromal cells, we first monitored the expression of ESR1 at the onset of 
decidualization. We noted that the expression of ESR1 in Esr1
f/f 
uteri is strongest in the 
glandular epithelium, lower in the stroma, and negligible in the luminal epithelium at 20h 
post administration of decidual stimulation (Fig. 2.3A, panel a). In comparison in the WE
d/d 
uteri, ESR1 is still expressed in the stroma but is absent from both luminal and glandular 
epithelium (Fig. 2.3A, panel b). The high expression of glandular ESR1 in Esr1
f/f 
uteri and its 
absence in the WE
d/d 
uteri led us to hypothesize that ESR1 in the glands might control the 
secretion of a factor which promotes stromal decidualization. One such factor that has been 
shown previously to be regulated by ESR1 and is of critical importance in implantation is LIF 
(18-20). Therefore, we examined the expression of Lif in Esr1
f/f 
and WE
d/d 
animals during 
decidualization. As shown in Fig.2. 3B, the expression of Lif was dramatically reduced in 
uteri lacking epithelial ESR1, while the levels of PGR and its target gene HAND2 remained 
unaltered between Esr1
f/f 
and WE
d/d 
uteri (Figs. 2.3B and 2.9). These results indicated that the 
loss of epithelial ESR1 does not affect the PGR-mediated signaling in uterus during 
decidualization. These results also suggested that LIF is a potential downstream target of 
ESR1 and might be involved in the regulation of stromal decidual response.  
To address the role of LIF in decidualization, we next investigated whether LIF is 
able to rescue the decidualization defect exhibited by the WE
d/d 
uteri. Recombinant mouse 
LIF was administered intraperitoneally to WE
d/d
 mice and subjected to experimentally-
induced decidualization. Uteri were dissected 72 h later, and the decidual response was 
measured. Remarkably we observed that LIF treatment restored the decidual response in the 
mutant uterine horns, as measured by morphological examination (Fig. 2.3C, compare panels 
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a, b, and c), alkaline phosphatase activity (Fig. 2.3C, compare panels d, e, and f) and wet 
weight gain (Fig. 2.3D). These results strongly support our hypothesis that LIF is a 
downstream effector of epithelial ESR1 and regulates stromal cell decidualization. 
  
LIF regulates stromal cell decidualization via paracrine-mediated signaling involving 
Ihh pathway 
To investigate the mechanism by which LIF promotes the differentiation of stromal 
cells, we first considered the possibility that LIF secreted from the glands act directly on 
stromal cells to promote decidualization. Stromal cells isolated from ESR1
f/f 
uteri were 
cultured in the presence and in absence of LIF. We observed that LIF by itself did not 
promote stromal differentiation, and when added along with P, LIF failed to exhibit any 
additive effect on stromal decidualization (Fig. 2.8A and 2.8B). These results indicated that 
LIF does not act directly on the stromal cells to induce decidualization. We next considered 
the possibility that LIF induces the expression of a factor in the luminal epithelium, which in 
turn acts on stromal cells to promote decidualization. A potential paracrine factor is IHH 
which has been shown previously to be secreted from the luminal epithelium, binds to it 
receptor PTCH1 in the stroma and induces the expression of Nr2f2, a transcription factor that 
promotes stromal cell decidualization (24, 25, 26, 27). Interestingly, LIF has been shown to 
regulate Ihh expression during pregnancy raising the possibility that LIF regulates stromal 
decidualization by inducing IHH (21). In order to test this possibility we monitored the 
expression of genes involved in the Ihh signaling cascade during decidualization. As shown 
in Fig. 2.3E, we observed a significant downregulation of the factors involved in Ihh 
signaling cascade in WE
d/d
 uteri during decidualization, indicating decidual impairment due 
to defective Ihh signaling. Importantly, administration of LIF to WE
d/d
 uteri was able to 
induce the expression of the genes involved in Ihh signaling and rescue the decidualization 
defect in the mutant uteri (Fig. 2.3F). Collectively, these results strongly indicate that LIF 
regulates differentiation of endometrial stromal cells via Ihh pathway.  
 
LIF and P act synergistically to induce Ihh via the MAPK pathway 
Previous studies have shown induction of Ihh by both P and LIF in the uterus during 
early pregnancy (21, 22). However, the mechanism by which either P or LIF induces IHH 
remains unknown (23). To gain an insight into the regulation of Ihh by P and LIF, we 
administered P and LIF to ovariectomized animals and monitored Ihh expression. As 
expected, Ihh was induced in uterine epithelial cells within 6 h of P injection. We observed a 
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similar induction of Ihh with LIF. However upon co-administration of P and LIF, there was a 
dramatic induction of Ihh indicating a synergistic action of P and LIF on Ihh expression (Fig. 
2.4A).  
We next investigated the signaling pathway that is functioning downstream of LIF 
and is involved in Ihh expression. Previous studies have shown that in the uterus LIF acts 
through Signal Transducer and Activator of Transcription (STAT3) to exert its effects on the 
luminal epithelium to promote receptivity during implantation (24, 25). In order to test this 
signaling mechanism we examined Ihh induction by P and LIF in the uteri of control (Stat3
f/f
) 
and epithelial knockout of Stat3 (SW
d/d
) animals. In SW
d/d
 mutants, Stat3 has been excised 
from the luminal and glandular epithelial cells of the uterus, thus blocking the signaling of 
LIF involving the JAK/STAT3 pathway. Our results show that LIF and P still retained the 
ability to act synergistically to induce Ihh in the SW
d/d
 uteri (Fig. 2.4B), indicating that LIF 
does not act via the STAT3 pathway to induce Ihh during pregnancy. LIF is also known to act 
via the MAPK signaling pathway to exert its effects on target cells (26-28). In order to 
examine whether the MAPK signaling pathway was activated downstream of LIF, we 
compared the expression levels of phosphorylated-ERK1/2 (p-ERK1/2) in uteri of animals 
treated with LIF, P or P along with LIF. An increase in the level of p-ERK1/2 as well as total 
ERK was observed in uterine epithelium of LIF treated samples (Fig. 2.4C, Fig. 2.10, 
compare panels a and b). This expression was further enhanced in response to P along with 
LIF (Fig. 2.4C, Fig. 2.10, compare panels b and d). P by itself also activated MAPK signaling 
pathway in the uterine epithelium but to a lower extent than LIF or P along with LIF (Fig. 
2.4C, compare panels b, c and d). Similarly, phospho-SHP2 an adaptor molecule in the 
MAPK signaling pathway was also activated in the same manner as p-ERK1/2 (Fig. 2.4D, 
compare panels a through d). Taken together, these results indicate that P and LIF synergize 
to induce Ihh by activation of MAPK pathway. Consistent with these results, we observed 
that administration of PD184352, an inhibitor of the ERK1/2 (29), to uteri led to 
downregulation of the MAPK pathway and concomitant suppression of Ihh production (Fig. 
2.4E compare panels a and b), while the levels of PGR remained unaltered in response to the 
treatment (Fig. 2.4F). 
We further investigated the regulation of Ihh expression in the uterus by monitoring 
the expression profiles of Lif, Ihh and p-ERK1/2 on different days of pregnancy. Lif is 
expressed in the uterus in a biphasic manner; its expression levels are high on day 1 and 2 of 
pregnancy but then decline to minimal levels by day 3. The levels increase again by day 4 
with a transient surge in E levels (Fig. 2.5A). The levels of Ihh are low on day 1 of 
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pregnancy. The levels increase on day 2 reaching maximum levels by day 3, followed by a 
reduction on day 4 of gestation (Fig. 2.5B). Levels of pERK1/2 are prominent in the uterine 
luminal epithelium from day 1 to 3 of pregnancy, reaching maximum levels on day 3, 
following which it is excluded from the luminal epithelium and is expressed in the stroma 
(Fig. 2.5C, panels a through d). These overlapping expression patterns of Lif, Ihh and 
pERK1/2 suggest a regulatory network wherein LIF and P via ERK1/2 signaling pathway 
regulate Ihh production.  
To establish this regulatory network, we administered PD184352, an inhibitor of the 
ERK1/2 pathway, to uterine horn on day 2 of pregnancy. When we looked at the expression 
of Ihh on day 3 of gestation, at a time when its expression is supposed to be highest, we 
observed a significant reduction in Ihh levels in comparison to untreated control uterine 
horns; however Pgr levels remain unaffected by this treatment indicating a specific effect of 
ERK inhibitor on Ihh induction (Fig. 2.5D).   Collectively, these data establish an intricate 
regulation of Ihh expression by LIF and P via the MAPK signaling pathway during early 
pregnancy.  
 
DISCUSSION 
This study, for the first time, provides genetic evidence that uterine epithelial Esr1 
signaling is indispensable for stromal cell decidualization, a key event for the onset and 
establishment of pregnancy. Earlier studies using global knockout of Esr1 have shown that 
Esr1 does not play a role in decidualization function (10, 30). The uteri of these mutant mice 
created by Lubahn et al, however, still expressed a truncated Esr1 that retained DNA and 
hormone binding activities raising the possibility that this residual Esr1 activity mediated the 
decidual response seen in these mutant mice (11, 31, 32). Thus, the role of Esr1 in the 
establishment of a differentiated uterus to support implantation remained unclear until now. 
The decidualization defect displayed in WE
d/d 
mice unequivocally supports a critical 
compartmental specific role of Esr1 in the regulation of stromal differentiation.  
Impaired decidual response in uteri lacking epithelial ESR1 pointed to a paracrine 
regulation of stromal differentiation by epithelial ESR1. A possible candidate of this 
paracrine mediator emerged when we noticed the distinct expression pattern of ESR1 in the 
uteri of Esr1
f/f
 and WE
d/d
 mice during early stages of decidualization. In Esr1
f/f
 uteri ESR1 
was expressed strongly in the glands while this expression was absent in WE
d/d
 uteri (Fig. 
2.2A). The difference in ESR1 expression pattern in decidual uteri of the two genotypes 
raised the possibility that ESR1 might be regulating the secretion of a critical factor from the 
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glands, which controls stromal cell decidualization. In WE
d/d
 uteri the lack of glandular ESR1 
prevents secretion of this factor leading to impaired decidual response. Indeed our studies 
revealed that LIF synthesized in the glandular epithelium is the downstream mediator of 
epithelial ESR1 and is involved in the control of stromal function.  
Although previous studies have shown that LIF plays a critical role in implantation 
and decidualization (25, 33), the molecular mechanism by which LIF controls decidualization 
of stromal cells has not been addressed to this date. A recent report indicated a direct effect of 
LIF’s action on the stromal cells during decidualization (34). Contrary to this report, our 
studies have shown that LIF does not exhibit a direct effect on stromal differentiation. 
Instead, LIF regulates decidualization in an indirect manner by controlling IHH signaling in 
the endometrial epithelium. It has been shown previously that P induces IHH in the 
endometrial epithelium, which then acts in the stroma to regulate expression of Nr2f2, an 
essential factor for stromal cell decidualization (35, 36). Our studies indicate that LIF acting 
in concert with P promotes maximal induction of Ihh during early pregnancy.  
Signaling by LIF is initiated when it binds to its receptors on the target cell. LIF is 
known to activate three distinct pathways, JAK-STAT3, Ras/ERK/MAP kinase and/or 
PI3kinase/AKT (37, 38). Previous studies have shown that in the uterus during implantation, 
LIF functions by activating JAK-STAT3 pathway (24, 39). In this study we show for the first 
time activation of MAPK pathway in response to LIF signaling in the uterus. We observed 
that induction of Ihh in response to LIF signaling remains unaffected in uteri lacking 
epithelial Stat3. Instead administration of PD184352, which inhibits ERK1/2 to uteri, resulted 
in a marked suppression of Ihh indicating activation of MAPK rather than JAK-STAT3 
pathway in response to LIF signaling. Consistent with these results we observed that Lif, Ihh, 
and pERK exhibit similar expression patterns in the uterus during early pregnancy. We noted 
that between days 1 to 4 of gestation, LIF is secreted from endometrial glands in a biphasic 
manner. On day 2 of gestation, LIF acts synergistically with P to induce Ihh via the 
Ras/ERK/MAPK pathway. The level of LIF in the uterus declines on day 3 and rises again on 
day 4 prior to implantation. The surge of LIF on day 4 activates JAK-STAT3 pathway in the 
luminal epithelial cells and regulates a distinct set of genes that are known to play critical 
roles in uterine receptivity and embryo implantation. 
Although research over the past decade has identified several factors that regulate 
uterine function during implantation (13, 19, 35, 36), there is only limited insight into the 
molecular mechanisms and signaling pathways that interconnect the various factors and 
steroid hormone signaling during early pregnancy.  
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Our studies for the first time reveal that a complex interplay of E and P signaling via 
their target molecules LIF and IHH in the glandular and luminal epithelium respectively is 
pivotal for successful differentiation of endometrial stroma during decidualization (Fig. 2.6). 
Based on the findings described herein, we propose that E acting via epithelial ESR1 induces 
the expression of LIF in the glands between days 1 to 2 of pregnancy. Glandular LIF in 
concert with P then act on the luminal epithelial cells to activate MAPK pathway and induce 
Ihh expression between days 2 to 3 of gestation. The activation of the hedgehog pathway 
involving IHH-PTCH1-NR2F2 then promotes differentiation of stromal cells during 
decidualization. In summary, we have uncovered a novel mechanism by which epithelial 
Esr1 in a paracrine manner controls decidualization of endometrial stromal cells.  
 
MATERIALS AND METHODS 
Mice, hormone treatments, and tissue collection  
All experiments involving mice were conducted in accordance with National 
Institutes of Health standards for the use and care of mice. The animal protocols were 
approved by the University of Illinois Institutional Animal Care and Use Committee. For 
mating studies, Esr1 
f/f
, WE
d/d
 female mice were housed with wild-type C57BL/6 male mice 
(Charles Rivers). The presence of a vaginal plug after mating was designated as day 1 of 
pregnancy. 
Female mice were subjected to bilateral ovariectomy. Two weeks later, mice were 
injected subcutaneously with vehicle (sesame oil) or P (1 mg) for 3 consecutive days. The 
animals were killed and uteri were collected after 24 h. In certain experiments mice were 
pretreated with P (1 mg) for 2 days before E (100 ng) administration. Uteri were collected 24 
h after E treatment and epithelial proliferation was assessed. 
Decidualization was experimentally induced in non-pregnant mice as described 
previously (14). Briefly, mice were first ovariectomized. Two weeks following ovariectomy, 
mice were injected with 100 ng of E in 0.1 ml of sesame oil for 3 consecutive days. This was 
followed by daily injections of 1 mg of P and 10 ng of E for 3 consecutive days. 
Decidualization was then initiated in one horn by injection of 50ul oil. The other horn was 
left unstimulated. The mice were treated with E+P additionally post stimulation, and then 
killed to collect the uterine tissue either 20h post stimulus or 72h post stimulus. For the 
rescue of decidualization, 100ul of Vehicle (PBS) or LIF (1ug in 100ul PBS) was added 
intraperitoneally every 2h for 8h pre-stimulus. Uteri were collected 20h or 72h post stimulus.  
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Uteri from different days of pregnancy were collected for RNA isolation and IHC. One horn 
of the uterus was fixed in 10% formalin prior to IHC, and the other horn was flash frozen in 
Liquid N2 prior to RNA isolation. 
 
Intralumninal administration of inhibitor 
MEK inhibitor PD184352, was initially dissolved in DMSO, and then diluted in 
HBSS. Ten μl of inhibitor (50 μM) was injected into one horn intraluminally 12h 
prestimulus, while the other horn served as vehicle control. LIF was administered as 
described above and uterine horns were collected 20h post stimulus. Similarly, 10 μl of 
inhibitor (50 μM) was injected into one horn intraluminally on day 2 of pregnancy, while the 
other horn served as vehicle control. Uterine horns were collected on day 3 of pregnancy. 
 
Isolation of uterine epithelial and stromal cells 
Uteri were removed at 0h, 20h or 72h post stimulus. With the aid of a dissecting 
microscope, each uterine horn was cut transversely into two equal segments. The tissues were 
then incubated in 10 ml of a solution of 0.5% bovine pancreatic trypsin (Cooper Biomedical, 
Malvern, PA) in Ca and Mg-free PBS, pH 7.4. Tissues were first incubated at 4ºC for 1 h and 
then at 37ºC for 40 min. After incubation, the uterine tissue was squeezed with forceps 
dissociating the epithelium from the uterine pieces. The epithelial fragments in the 
supernatant were collected with a pipette; this procedure was repeated three or four times. 
The epithelial fragments were collected by centrifugation at 100 X g for 5 min. The resulting 
cell pellet was subjected to RNA isolation protocol. 
The remaining uterine tissue was incubated with 0.5g/L collagenase at 37ºC for 40 
min. After incubation, the tube was shaken vigorously and the supernatant was passed 
through a 70um mesh to remove tissue debris. Stromal cells were collected by centrifugation 
at 1700 X g for 5 min. For primary stromal cell culture, cells were grown in DMEM/F-12 
medium containing 5% charcoal-stripped FBS. To induce in vitro decidualization, the cells 
were treated with or without a hormone cocktail containing 1 nM E, 1 mM P for 24-72h. 
 
Culture of uterine stromal cells 
The uterine stromal cells, isolated as described above, were diluted in Dulbecco’s 
modified Eagle’s Medium-F12 medium (DMEM-F12; with 100 unit/L penicillin, 0.1 g/L 
streptomycin, 1.25 mg/L Fungizone) with 2% heat-inactivated fetal calf serum. The live cells 
were counted by trypan blue staining using a hemocytometer. Cells were then seeded in 6-
well cell culture plates. The unattached cells were removed by washing several times with 
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HBSS after 2 h, and cell culture was continued after addition of fresh medium supplemented 
with P (1 mM) and E (10 nM). 
 
Real-time PCR analysis 
Uterine tissue was either homogenized or uterine epithelium was isolated and total 
RNA was extracted by using TRIZOL reagent, according to the manufacturer’s protocol. 
cDNA was prepared by standard protocols. The cDNA was amplified to quantify gene 
expression by real-time PCR, using gene-specific primers and SYBR Green (Applied 
Biosystems, Warringtom, UK). The expression level of Rplp0 (36B4) or Cytokeratin 18 
(Ck18) was used as the internal control. For each treatment, the mean Ct and standard 
deviation were calculated from individual Ct values obtained from three replicates of a 
sample. The normalized ΔCt in each sample was calculated as mean Ct of target gene 
subtracted by the mean Ct of internal control gene. ΔΔCt was then calculated as the 
difference between the ΔCt values of the control and treatment sample. The fold change of 
gene expression in each sample relative to a control was computed as 2
- ΔΔCt
. The mean fold 
induction and standard errors were calculated from three or more independent experiments.  
 
Immunohistochemistry 
Formalin fixed uterine pieces were processed for paraffin embedding. Cross sections 
(5um thickness) were mounted onto microscope slides (Fisher Scientific). For 
immunostaining, uterine sections were deparaffinized in xylene (three times for 5 min each), 
rehydrated through a graded series of treatment with ethanol (100%, 95%, 85%, and 70% for 
5 min each), and rinsed in tap water. For all samples, antigen retrieval was performed by 
boiling the sections in 0.01 M sodium citrate buffer (pH 6.0) for 20 min, followed by 
incubation at RT for 30 min. A 5% solution of normal donkey serum (Jackson 
Immunoresearch) in PBS was used as a blocking buffer. Sections were incubated with the 
following primary antibodies diluted in blocking solution (0.25% bovine serum albumin 
[BSA], 0.3% Triton X-100, sterile PBS) overnight at 4°C: PH3 (BD Pharmingen), pSTAT3-
TY 705 (ABCAM), pERK1/2 (Santa Cruz), ERK1/2( Santa Cruz), pShp2 (ABCAM), ESR1 
(Novus Biologicals). The sections were washed and incubated with either biotinylated 
secondary antibodies (Jackson Immunoresearch Laboratories Inc.) secondary antibodies for 
60 min. This was followed by incubation with streptavidin-conjugated horseradish peroxidase 
(Histostain kit; Zymed Laboratories Inc.) for 45 min. Sections were stained with 3-amino-9-
ethyl carbazole (AEC) solution (Zymed Laboratories Inc.) and counterstained with Mayer’s 
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hematoxylin (Sigma). Stained sections were mounted in diazabicyclo (2, 2, 2) octane 
(DABCO), Tris-Cl (pH 8.5), and sterile double- distilled water (ddH2O)]. Negative controls 
included incubation with donkey serum and omission of the primary antibody for all samples.  
 
Image capture and quantitation of immunostaining  
The images of immunohistochemical staining were captured by using a Leica 
(Nussloch, Germany) DM2500 light microscope fitted with a Qimaging Retiga 2000R 
camera (Qimaging, British Columbia, Canada). For counting, at least 5 to 6 individual 20x 
fields from each sample were captured. The numbers of positively stained uterine 
LE nuclei in each field were averaged and expressed as a percentage of the total 
number of these cells. Images were processed on ADOBE Photoshop version 8. The standard 
deviation was determined for each averaged total. ANOVA single-factor analysis was 
conducted on the grouped means to determine statistical significance at a significance of a P 
value of < 0.01.  
 
Statistical analysis 
Statistical analysis was performed by t-test or ANOVA. The values were expressed as 
mean ± SEM and considered significant if p<0.01. 
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Figure 2.1.  Ablation of Esr1 in the uterus epithelium leads to a defect in stromal 
cell decidualization. A. Uterine cross sections from Esr1
f/f
 and Esr1
d/d
 mice were 
subjected to immunohistochemistry using anti-ESR1.  Esr1
d/d
 mice display efficient 
deletion of ESR1 (b) when compared to Esr1
f/f
 control mice (a). B .Esr1
f/f
 and Esr1
d/d
 
mice were subjected to an artificial decidual stimulus. Uteri were collected 72 hours 
after administration of oil stimulus. Esr1
d/d
 uteri fail to give a decidual response.  
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Figure 2.1 (cont.) C. Ratio of right to left horn in weight. Esr1d/d uterine horns fail to 
decidualize. D. Alkaline phosphatase activity was detected in the decidualized stroma. 
(a) sections of Esr1
f/f
 uteri (b) sections of Esr1
d/d 
uteri. Purple color indicates alkaline 
phosphatase activity. 
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Figure 2.2  Uterine epithelial ESR1 is indispensable for stromal cell decidualization. A. 
WE
d/d
 mutants have decidualization failure. Esr1
f/f
, 72 h after stimuli. The right horn (R) was 
stimulated, and the left horn (L) was unstimulated. Only right horn is decidualized. WE
d/d
, 72 
h after stimuli. Neither right (stimulated) nor left (unstimulated) horn is decidualized. B. 
Ratio of right to left horn in weight. WE
d/d
 uterine horns fail to decidualize. *p≤ 0.001 (t-test, 
n=5). 
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Figure 2.2 (cont.) C. Cell proliferation was measured by Ki67 immunostaining in uterine 
sections of Esr1
f/f
 (upper panel) and WE
d/d 
(lower panel) mice, 20h after decidual stimulation. 
Magnification: a and c: 10x, b and d: 20x. D. Percentage of Ki67-positive cells in the stromal 
compartment of Esr1
f/f
 and WE
d/d 
mice, 20 h after decidual stimulation. The data represents 
average number of cells from multiple fields of multiple uterine sections. *p≤ 0.01 (t-test, 
n=4). 
C 
D 
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Figure 2.2 (cont.) E. Stromal cells were isolated from uteri 20 h after decidual stimulation 
and total RNA was prepared. Real-time PCR was performed to monitor the expression of 
mRNAs corresponding to the cell cycle genes Ccne1, Ccne2, Ccnd1, Cdk2, Cdk4 and Cdk6. 
Rplp0 encoding a ribosomal subunit protein was used as internal control to normalize gene 
expression. The data are represented as the mean fold induction ± SEM, *p ≤ 0.01. F. 
Alkaline phosphatase activity was detected in the decidualized stroma. (a) sections of Esr1
f/f
 
uteri (b) sections of WE
d/d 
uteri. Purple color indicates alkaline phosphatase activity. 
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Figure 2.3. LIF regulates stromal cell decidualization via IHH. A. ESR1 is 
differentially expressed in the uterus during decidualization. (a) Esr1
f/f
, ESR1 20 h after 
stimuli, black arrows indicate glandular expression (b) WE
d/d
, ESR1 20 h after stimuli, 
black arrows indicate lack of glandular expression.  B. Real-time PCR was performed to 
monitor the expression of Lif and Pgr in the uterus of Esr1
f/f 
and WE
d/d
 mice at 20h post 
stimuli. Ck18, encoding an epithelial specific protein was used as internal control to 
normalize gene expression. The data are represented as the mean fold induction ± SEM, 
*p ≤ 0.01. 
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Figure 2.3 (cont.) C. LIF rescues stromal cell decidualization in WE
d/d
 mice. Esr1
f/f
 and 
WE
d/d
 mice were subjected to experimentally induced decidualization with vehicle (Saline) or 
LIF. Uteri were assessed for gross anatomy and ALP activity 72h after stimuli. (a, d) Esr1
f/f
 
mice treated with vehicle; (b, e) WE
d/d
 mice treated with vehicle; (c, f) WE
d/d
 mice treated 
with LIF (a) Esr1
f/f
 with vehicle. The right horn (R) was stimulated, and the left horn (L) was 
unstimulated, R decidualizes, L does not decidualize. (b) WE
d/d
 without LIF, neither R 
(stimulated) or L (unstimulated) horn is decidualized. (c) WE
d/d
 with LIF, R decidualizes, L 
does not decidualize. ALP activity is strong in (d), absent in (e), and restored in (f). D. Ratio 
of right to left horn in wet weight. LIF rescues wet weight gain defect in WE
d/d
 mice. *p≤ 
0.001 (t-test, n=7).  
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Figure 2.3 (cont.) E. Ihh signaling is downregulated in WE
d/d  
mice uteri. Real-time PCR was 
performed to monitor the expression of Ihh, Ptch1 and Nr2f2 in the uterus of Esr1
f/f 
and WE
d/d
 
mice at 20h post stimuli. The level of Rplp0 or Ck18 was used as internal control to 
normalize gene expression. F. Ihh signaling is restored in WE
d/d 
 mice during the rescue of 
decidualization by LIF. Real-time PCR was performed to monitor the expression of Ihh, 
Ptch1 and Nr2f2 in the uterus of WE
d/d
 treated with Saline or LIF at 20h post stimuli.  The 
level of Rplp0 or Ck18 was used as internal control to normalize gene expression. The data 
are represented as the mean fold induction ± SEM, *p ≤ 0.01, **p≤ 0.001 
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Figure 2.4.  LIF and P act synergistically to induce expression of Ihh. A. Expression 
level of Ihh mRNA in the LE of WT overectomized mice injected with Oil, P (1mg), LIF 
(1ug, 3 injections at 2h intervals) or P+LIF. LE was isolated at 6 h post injection. The data 
are represented as the mean fold induction ± SEM, *p ≤ 0.01, **p ≤ 0.001. B. Expression 
level of Ihh mRNA in the LE of Stat3
f/f 
and SW
d/d
 ovariectomized mice injected with Oil, 
P (1mg), LIF (1ug, 3 injections at 2h intervals) or P+LIF. LE was isolated at 6 h post 
injection. The data are represented as the mean fold induction ± SEM. 
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Figure 2.4 (cont.) C. Immunohistochemical localization of pERK1/2 in WT overectomized 
mice uteri injected with (a) Oil, (b) LIF (1ug, 3 injections at 2h intervals), (c) P (1mg) or (d) 
P along with LIF for 6h. D. Immunohistochemical localization of pSHP2 of WT 
overectomized mice uteri injected with (a) Oil, (b) LIF (1ug, 3 injections at 2h intervals), (c) 
P (1mg) or (d) P along with LIF for 6h.   
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Figure 2.4 (cont.) E. Downregulation of ERK1/2 in the uterus inhibits Ihh induction by LIF. 
Immunohistochemical localization of pERK1/2 in WT overectomized mice uteri pretreated 
with (a) Saline and P along with LIF (b) PD184352 and P along with LIF, for 6h. Note 
reduced expression of pERK1/2 in LE of uteri treated with PD184352. F. Real-time PCR was 
performed to monitor the expression of Ihh in the uterus of WT mice treated with DMSO and 
(P along with LIF in Saline) or PD184352 and (P along with LIF in Saline). Ck18 was used 
as internal control to normalize gene expression. 
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Figure 2.5. LIF in conjunction with P regulates Ihh expression during pregnancy. A. 
Real-time PCR was performed to monitor the expression of mRNAS corresponding to Lif in 
uterus on days 1 to 4 of gestation. The relative levels of gene expression on different days of 
pregnancy were determined by setting the expression level of Lif mRNA on day 1 of 
pregnancy at 1.0. Ck18, an epithelium specific protein, was used as internal control to 
normalize gene expression. B. Real-time PCR was performed to monitor the expression of 
mRNAs corresponding to Ihh in uterus on days 1 to 4 of gestation. The relative levels of gene 
expression on different days of pregnancy were determined by setting the expression level of 
Ihh mRNA on day 1 of pregnancy at 1. 0. Ck18, encoding an epithelium specific protein, was 
used as internal control to normalize gene expression.   
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Figure 2.5 (cont.) C. Uterine sections from day 1 to day 4 (a–d) of pregnancy were subjected 
to immunohistochemical analysis using anti-pERK1/2 antibody. L, G and S indicate luminal 
epithelium, glandular epithelium and stroma, respectively.   
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Figure 2.5 (cont.) D. Real-time PCR was performed to monitor the expression of Ihh, Pgr  in 
uterine horns of WT day 3 pregnant mice treated with either DMSO or PD184352. Ck18 was 
used as internal control to normalize gene expression. The data are represented as the mean 
fold induction ± SEM, *p ≤ 0.01, **p≤0.001 
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Figure 2.6 Conceptual model of epithelial ESR1 action in the mouse uterus during 
implantation. In the preimplantation uterus around day 1-2 of pregnancy, E acting through 
its receptor ESR1 induces Lif production in the glands. LIF secreted from the glands, acts via 
the LIF receptors on the luminal epithelium and activates ERK signaling synergistically with 
P which acts through its receptor PGR. The JAK-STAT3 pathway is not activated by LIF in 
the luminal epithelial cells at this time. Activated MAPK then functions as a downstream 
effector of LIF and P to induce the expression of Ihh in the luminal epithelium. IHH secreted 
from the luminal epithelium activates the IHH-PTCH1-NR2F2 signaling cascade in the 
uterine stromal cells. These chain of signaling events help promote stromal proliferation and 
differentiation, which are key events during early pregnancy. 
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Figure 2.7 Deletion of Esr1 expression in the uterus of WE
d/d
 mice. A. Uterine epithelial 
RNA was extracted from Esr1
f/f
 and WE
d/d
 mice on day 4 of pregnancy (n= 3) and analyzed 
by Real-time PCR. Relative levels of Esr1 mRNA expression in uterine epithelium WE
d/d 
mice are compared to those in Esr1
f/f
 control mice. Ck18 was used as internal control to 
normalize gene expression. The data are represented as the mean fold induction ± SEM, **p 
< 0.001. B. Immunohistochemical localization of ESR1 in the uterus of Esr1
f/f
 and WE
d/d 
18h 
after E treatment. Note the absence of glandular and epithelial expression of ESR1 in WE
d/d
 
uteri, whereas stromal expression is intact. 
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Figure 2.8 LIF does not have a direct on stromal cell decidualization. Real-time PCR was 
performed to monitor the expression of mRNAS corresponding to Prp (A) and Alp (B) in 
isolated stromal cells from hormone primed WT mice uteri treated with vehicle, LIF 
(100ng/ml), P (1um) or P along with LIF for 72h. Rplp0, was used as internal control to 
normalize gene expression 
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Figure 2.9 PGR expression and its downstream target Hand2 in the stroma, is not 
affected in WE
d/d 
mice. Immunohistochemical localization of PGR (upper panel) and 
HAND2 (lower panel) in the uterus of Esr1
f/f
 and WE
d/d 
20h after decidualization.  
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Figure 2.10 Expression of ERK in the uterus is altered by hormone and LIF treatment 
Immunohistochemical localization of ERK1/2 of WT overectomized mice uteri injected with 
(a) Oil, (b) LIF (1ug, 3 injections at 2h intervals), (c) P (1mg) or (d) P along with LIF for 6h. 
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Result of six month breeding study are shown 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1. Ablation of uterine epithelial Esr1 leads to infertility 
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Role of Signal Transducer And Activator Of Transcription 3 during Implantation  
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ABSTRACT 
Embryo implantation is regulated by a variety of endometrial factors, including 
cytokines, growth factors and transcription factors. Earlier studies identified the leukaemia 
inhibitory factor (LIF), a cytokine produced by uterine glands, as an essential regulator of 
implantation. LIF, acting via its cell surface receptor, activates the signal transducer and 
activator of transcription 3 (STAT3) in the uterine epithelial cells. However, the precise 
mechanism via which activated STAT3 promotes uterine function during implantation 
remains unknown. To identify the molecular pathways regulated by STAT3, we created SW
d/d
 
mice in which Stat3 gene is conditionally inactivated in uterine epithelium. The SW
d/d
 mice 
are infertile due to a lack of embryo attachment to the uterine luminal epithelium and 
consequent implantation failure. Gene expression profiling of uterine epithelial cells of SW
d/d
 
mice revealed dysregulated expression of specific components of junctional complexes, 
including E-cadherin, - and β-catenin, and several claudins, which critically regulate 
epithelial junctional integrity and embryo attachment. Additionally, uteri of SW
d/d
 mice 
exhibited markedly reduced stromal proliferation and differentiation, indicating that epithelial 
STAT3 controls stromal function via a paracrine mechanism. The stromal defect arose from a 
drastic reduction in the production of several members of the epidermal growth factor (EGF) 
family in luminal epithelium of SW
d/d
 uteri and the resulting lack of activation of EGF 
receptor signaling and mitotic activity in the stromal cells. Collectively, our results uncovered 
an intricate molecular network operating downstream of STAT3 that regulates uterine 
epithelial junctional reorganization, and stromal proliferation and differentiation, which are 
critical determinants of successful implantation.  
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INTRODUCTION 
In mammals, a hormonally-primed receptive uterus is a pre-requisite for attachment of 
the embryo to the uterine epithelium to initiate the process of implantation (1,2). Failure of 
implantation due to a non receptive uterus is a major cause of infertility in humans (3,4). In 
rodents and primates, the attached embryo breaches the uterine luminal epithelium during 
implantation and invades the underlying stromal compartment to trigger a remarkable 
transformation of the stromal tissue (5-7). During this process, known as decidualization, the 
fibroblastic stromal cells proliferate and subsequently differentiate into distinct decidual cells, 
which support the growth and development of the implanted embryo until placentation ensues 
(7). 
Implantation is regulated by a timely interplay of various transcription factors, 
cytokines and growth factors (1,8,9). Spatio-temporal expression analyses have revealed that 
these factors are expressed in various uterine compartments, such as luminal epithelium, 
glandular epithelium, and stroma, overlapping the window of implantation (8,10-12). 
Extensive research over the past decade, using genetically altered mutant mouse models, has 
identified a number of factors that critically regulate uterine function in the preimplantation 
and post implantation phases of pregnancy (5,13-16). Colin Stewart and co-workers were the 
first to describe an obligatory role of the leukaemia inhibitory factor (LIF) in implantation 
(17). In female mice lacking LIF, the embryos fail to attach to the luminal epithelium due to a 
defect in uterine receptivity (8,17). While it is clear that during implantation, LIF, secreted 
from the glands, binds to its receptors in luminal epithelial cells and activates the JAK-STAT 
pathway, there is only limited insight into the molecular mechanisms that function 
downstream of STAT signaling to promote uterine receptivity for embryo implantation (18-
20).  
It was previously reported that STAT3, a member of the STAT family of transcription 
factors, is activated in uterine luminal epithelium in response to LIF signaling, raising the 
possibility that downstream pathways regulated by STAT3 help create the receptive state of 
the uterus during implantation (18,21). Global deletion of Stat3 gene is embryonic lethal, 
necessitating the development of conditional deletion of this gene to study its function during 
implantation (22). We, therefore, performed a conditional knockout of the Stat3 gene in the 
uterus of adult mice by employing the Cre-LoxP strategy (23). This resulted in the creation of 
mutant mice in which Stat3 is specifically ablated in the uterine epithelium, but is retained in 
the stroma. Using this unique mouse model, we uncovered the mechanisms by which LIF 
regulates uterine epithelial and stromal functions during the receptive phase. Our studies 
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revealed that LIF, by activating STAT3, regulates uterine epithelial junctional integrity and 
cell-cell communication, and influences paracrine signaling between epithelial and stromal 
compartments to control uterine proliferation and differentiation. Collectively, these studies 
provide novel insights into the mechanisms by which LIF-STAT3 signaling allows transition 
of uterine epithelium and stroma to proper functional states that permit embryo attachment 
and invasion.   
 
RESULTS 
Biphasic expression and activation of STAT3 in the preimplantation uterus 
The spatio-temporal profiles of Stat3 mRNA and the active phosphorylated form of 
STAT3 protein were examined in the mouse uterus during early pregnancy by real-time PCR 
and immunohistochemistry (IHC), respectively. As shown in Figure 3.1A, the expression of 
Stat3 mRNA, which was high on day 1 of pregnancy, decreased to low levels by day 3. This 
was followed by a second rise in mRNA levels on day 4 at the time of embryo implantation. 
Consistent with the mRNA profile, we observed prominent expression of active STAT3 
protein, phosphorylated at Y705, in uterine luminal epithelium on day 1 of pregnancy (Figure 
3.1B, panel a). The level of phospho STAT3 declined on days 2 and 3 of gestation (Figure 
3.1B, panel b and c), but reappeared in uterine luminal and glandular epithelium on day 4 at 
the time of implantation (Figure 3.1B panel d). The level of phospho STAT3 increased 
further on day 5 of gestation. Interestingly, this later expression was localized to both luminal 
epithelium and sub-luminal stroma (Figure 3.1B, panel e). The biphasic expression and 
activation of STAT3 in the periimplantation uterus showed a striking overlap with previously 
reported biphasic LIF expression in the uterus during early pregnancy (25,26). This 
observation supports the view that LIF is a modulator of STAT3 activation in the uterus 
during this critical period. 
 
Conditional ablation of Stat3 in the uterine epithelium leads to infertility  
Earlier studies also localized the LIF receptor predominantly in the luminal 
epithelium [18], indicating that an analysis of STAT3 activation and function in this tissue 
would provide a critical understanding of the molecular events controlled by LIF during early 
pregnancy. To investigate the function of STAT3 in the uterine epithelium, we created a 
conditional knockout of Stat3 in the uteri of adult mice. Transgenic mice expressing Cre 
under the control of Wnt-7a promoter was previously used to ablate “floxed” genes 
selectively in uterine epithelial cells (27,28) We, therefore, crossed the Wnt7a-Cre mice with 
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mice harbouring “floxed” Stat3 (Stat3f/f) (29-31) to create SWd/d mice. In uterine epithelial 
cells of SW
d/d
 mice, Cre recombinase deletes exon 22 of Stat3, which encodes the tyrosine 
residue (Y705) essential for STAT activation.  
We employed real-time PCR and immunohistochemistry (IHC) to confirm the 
deletion of Stat3 in the uterine epithelium of these mutant mice. As shown in Figure 3.8A, 
Stat3 mRNA was markedly downregulated in uterine epithelial cells, but not in the stromal 
cells, of SW
d/d
 mice on day 4 of pregnancy. Similarly, STAT3 protein was robustly expressed 
throughout Stat3
f/f
 uterine epithelium on day 4 of pregnancy, whereas SW
d/d
 mice display 
STAT3 expression solely in the stromal tissue (Fig 3.8B) confirming successful abrogation of 
Stat3 gene specifically in uterine epithelium of SW
d/d
 mice. 
A six-month breeding study demonstrated that SW
d/d
 mutant mice are infertile (Table 
1). While Stat3
f/f
 mice exhibited normal litter size and pregnancy rates, the SW
d/d
 females 
failed to become pregnant when mated
 
with wild-type males. However copulatory plugs were 
observed upon mating, indicating normal mating behavior. To investigate the cause of 
infertility in SW
d/d
 females, we examined their ovarian functions by inducing superovulation. 
Prepubertal Stat3
f/f
 and SW
d/d
 mice were treated with a regimen of gonadotropins as described 
in Materials and Methods. We observed that, upon gonadotropin stimulation, the number of 
eggs produced by the Stat3
f/f
 females was comparable to that produced by the SW
d/d
 females 
(Figure 3.9A), indicating that ovulation is not affected in these mutant mice. To further 
examine the ovulation and fertilization in these mice under normal physiological conditions, 
blastocysts were recovered from uteri of Stat3
f/f
 and SW
d/d
 mice on day 4 of pregnancy prior 
to implantation. Once again, no significant difference was found in either the number or the 
morphology of the embryos recovered from Stat3
f/f
 and SW
d/d
 uteri (Figure 3.9B and data not 
shown). In further support of normal ovarian activity, the serum levels of progesterone (P) 
and estrogen (E) were found to be comparable in Stat3
f/f
 and SW
d/d
 females on day 4 of 
pregnancy (Figures 3.9C and 3.9D). Collectively, these results suggested that the infertility of 
SW
d/d
 females is not due to impairment
 
in the hypothalamic-pituitary-ovarian axis or lack of 
fertilization, but is likely due to defective implantation or pregnancy failure following 
implantation. 
 
Deletion of Stat3 from uterine epithelium prevents embryo attachment 
In mice, attachment of the embryos to the uterine wall is accompanied by increased 
vascular permeability at the implantation sites, which can be scored visually as distinct blue 
bands following an intravenous injection of Chicago blue dye (32). As shown in Figure 3.2A, 
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Stat3
f/f
 mice displayed distinct implantation sites on day 5 of pregnancy. In contrast, the SW
d/d
 
females did not show any sign of implantation. Histological analysis of uterine sections from 
Stat3
f/f
 females on day 5 of pregnancy showed, as expected, a close contact of embryonic 
trophectoderm with uterine luminal epithelium (Figure 3.2B, panel a). In contrast, in SW
d/d
 
uteri, embryos did not attach to luminal epithelium. Instead, blastocysts remained free-
floating in the lumen (Figure 3.2B, panel b). Taken together, these results indicated that the 
loss of Stat3 expression in the uterine epithelium resulted in the inability of the luminal 
epithelium to attach to the embryos. 
 
STAT3 regulates junctional remodelling in uterine luminal epithelium 
To gain insights into the mechanisms underlying the implantation defect observed in 
SW
d/d
 mice, we isolated luminal epithelial cells from Stat3
f/f
 and SW
d/d
 uteri on day 4 of 
pregnancy and performed gene expression profiling, using Affymetrix Mouse GeneChip 
arrays. Interestingly, our study revealed an up-regulation of transcripts corresponding to two 
distinct classes of junctional molecules, catenins and claudins, in SW
d/d
 uterine epithelium 
compared to Stat3
f/f
 control uteri. The microarray data (GEO accession # GSE44087) was 
validated by real-time PCR analysis. As shown in Figure 3.3A, we confirmed a marked up-
regulation of mRNAs corresponding to claudins 1, 3, and 4 and alpha (α) and beta (β) catenin 
in the luminal epithelium of SW
d/d
 uteri.  
An important feature of the receptive uterus is the reorganization of junctional 
proteins in uterine epithelial cell membrane at the time of implantation. In the nonreceptive 
state, E-cadherin, a Ca
2+
-dependent transmembrane adhesion molecule, connects adjacent 
epithelial cells by linking their cytoskeletons via catenins to help maintain cell-cell adhesion 
and apical-basal polarity (31,33). Similarly, claudins, which are components of tight 
junctions, help maintain a paracellular barrier between the cells of an epithelium (34,35). 
These junctional proteins associate with various peripheral membrane proteins, which are in 
turn connected to the actin cytoskeleton. As the uterus attains receptive status, the epithelial 
cell junctions are reorganized as evidenced by the redistribution of membrane proteins at 
junctional complexes, resulting in the loss of cell polarity that allows acquisition of 
adhesiveness for the embryo (36,37).  
We next investigated whether the non-receptive state of the uterine epithelium of 
SW
d/d
 mice is associated with an altered expression of specific junctional proteins, such as E-
cadherin, -catenin and claudin-1, in the epithelial junctions. As shown in Fig. 3.3B (panel a), 
low levels of E-cadherin expression were seen only in the apical tips of Stat3
f/f
 uterine 
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epithelium during the receptive phase. The lateral junctions were devoid of any E-cadherin 
expression. Low levels of β-catenin were present in lateral junctions of Stat3f/f uterine 
epithelium (Fig. 3.3B, panel b). In contrast, in SW
d/d
 uterine epithelium, prominent expression 
of E-cadherin was observed in both apical and lateral junctions (panel d) and markedly 
elevated levels of β-catenin were seen in the lateral junctions (panel e). Interestingly, E-
cadherin and -catenin were co-localized specifically in the lateral junctions of SWd/d uterine 
epithelium, consistent with the presence of intact intercellular cadherin-catenin adherent 
junctional complexes (Figure 3.3B, panel f).  
We also examined the status of the tight junctions in Stat3
f/f
 and SW
d/d
 uterine 
epithelia. As shown in Figure 3.3C, the claudin-1 (CLDN1) protein, which was barely 
detectable in Stat3
f/f
 luminal epithelium (panel b), was present in the apical and basolateral 
junctions of SW
d/d
 uterine epithelium (panel e). Collectively, these results suggested that, in 
the absence of epithelial Stat3, proper reprogramming of luminal epithelial membrane 
proteins fails to occur with consequent dysregulated distribution of adherent and tight 
junctional complexes and lack of epithelial function required for embryo attachment. 
 
LIF-induced STAT3 activation triggers uterine epithelial reorganization 
We next examined whether LIF-induced activation of STAT3 during the transition of 
uterine luminal epithelium from non-receptive to receptive phase is accompanied by altered 
expression and redistribution of the catenins, claudins and E-cadherin in uterine epithelial 
junctional complexes. In this experiment, we used the delayed implantation model in which 
pregnant mice are ovariectomized to remove the source of ovarian hormones and then treated 
with exogenous LIF to initiate embryo attachment to uterine luminal epithelium. Our results 
revealed that uterine epithelial STAT3 remains unphosphorylated (at Y705), cytosolic, and 
inactive in the absence of exogenous LIF (Figure 3.3D, panels a and b). Both apical and 
lateral junctions of luminal epithelium contained E-cadherin (green, panel c), and β-catenin 
(red) was present mainly in the lateral junctions. Prominent expression of claudin-1 was 
observed in both apical and basolateral surfaces of the uterine luminal epithelium (panel d). 
Interestingly, administration of LIF, which initiated implantation in delayed mice, also led to 
phosphorylation (at Y705) and nuclear localization of phosphorylated STAT3 in uterine 
epithelial cells (panels e and f), however total STAT3 protein levels remain unaltered 
(compare panel a and e). We noted concomitant downregulation of E-cadherin at epithelial 
apical and lateral adherent junctions (panel g). In the presence of LIF, -catenin staining, 
although reduced, was still detectable in the lateral surfaces. We observed marked 
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downregulation of CLDN1 in the uterine luminal epithelial apical and basolateral tight 
junctions in response to exogenous LIF (Figure 3.3D, compare panels d and h). Taken 
together, our results are consistent with the hypothesis that LIF-mediated activation of 
STAT3 critically regulates the dynamics of uterine luminal epithelial adherent and tight 
junctional complexes containing E-cadherin/β-catenin and claudin-1, respectively. Hence, we 
propose that a major cause of implantation failure in mice lacking uterine epithelial Stat3 is 
the inability of LIF to downregulate the expression and distribution of critical components of 
epithelial junctional complexes. The resulting epithelium fails to present a proper surface for 
attachment to the embryonic trophectoderm and remains non-receptive and refractive to 
implantation. 
 
Ablation of Stat3 in the uterine epithelium leads to a defect in decidualization  
During implantation, embryo attachment to the uterine epithelium is followed by 
decidualization of underlying stromal cells (7,38). Since embryos fail to attach to epithelium 
of SW
d/d
 uteri, we assessed the decidual response in these mutant mice by performing 
experimentally-induced decidualization, which occurs independent of embryo attachment, as 
described previously (24). Ovariectomized Stat3
f/f
 and SW
d/d
 mice were treated with a well-
established regimen of steroid hormones and then decidualization reaction was initiated in 
one uterine horn by intra luminal injection of oil while the other horn was left unstimulated. 
We then examined the gross anatomy of the stimulated and unstimulated uterine horns of 
Stat3
f/f
 and SW
d/d
 mice. As expected, the uterine horns of Stat3
f/f
 mice exhibited a robust 
decidual response at 72 h after receiving the artificial stimulation (Figure 3.4A, panel a). In 
contrast, the SW
d/d
 uteri under identical conditions showed a drastically reduced decidual 
response (Figure 3.4A, panel b). When the decidual response was assessed by measurement 
of uterine wet weight gain, the SW
d/d
 uteri exhibited a markedly reduced weight gain relative 
to that seen in the Stat3
f/f
 uteri (Figure 3.4B). 
 
Uterine epithelial Stat3 regulates stromal proliferation during decidualization  
During decidualization, the uterine stromal cells initially undergo proliferation for 24–
48 h followed by differentiation (39). To further investigate the decidualization defect in mice 
lacking Stat3 in uterine epithelium, we monitored the proliferation and differentiation of 
steroid hormone-primed stromal cells in response to a decidual stimulation, using known 
markers of these events. As shown in Figure 3.4C panel a, uteri of Stat3
f/f
 mice exhibited an 
intense staining for Ki67 in the stromal cells within 20 h of receiving the decidual stimulus, 
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clearly indicative of extensive stromal cell proliferation, which is typically seen during 
normal pregnancy in response to embryo attachment (Figure 3.4C, panel c). In contrast, the 
uterine sections from SW
d/d
 mice showed a markedly altered pattern of Ki67 staining under 
identical conditions (Figure 3.4C, panels b and d). A generally reduced proliferative activity 
was observed in the stromal compartment of the mutant uteri. However, a few bands of 
proliferative cells persisted in the sub-epithelial stroma, indicating that proliferation of these 
cells is independent of epithelial STAT3. Quantitation of the Ki67 signal in areas of reduced 
proliferation revealed a significant reduction in the number of Ki67-positive cells in the 
stromal compartment of the SW
d/d
 uteri (Figure 3.4D), indicating a defect in stromal cell 
proliferation in these mutant mice. 
We further investigated the proliferation defect in SW
d/d
 uterine stroma by analyzing 
the expression of factors that control various cell cycle checkpoints, including cyclins, cyclin-
dependent kinases (Cdks), and Cdk inhibitors (40). Our results revealed a marked down 
regulation of cyclin E1 (Ccne1) and E2 (Ccne2) in stromal cells of SW
d/d
 uteri on day 5 of 
pregnancy. In contrast, the level of p21, an inhibitor of cyclin E was upregulated in stromal 
cells of SW
d/d
 uteri during decidualization (Figure 3.4E). 
We next investigated whether uterine stromal differentiation is also impaired in the 
absence of epithelial Stat3. Our results revealed an intense expression of alkaline 
phosphatase, a classical marker of decidualization, in the decidual cells of Stat3
f/f
 uteri at 72 h 
following decidual stimulation. In contrast, no expression of this decidual marker was seen in 
the uteri of SW
d/d
 mice at a similar time point, indicating a complete blockade of stromal cell 
differentiation in these mice (Figure 3.4F, compare panels a and b). Taken together, our 
results indicated that Stat3 is a critical regulator of stromal cell proliferation as well as 
differentiation during decidualization. 
 
Uterine epithelial STAT3 controls EGF receptor signaling in the stroma 
A defect in stromal proliferation resulting from ablation of uterine epithelial Stat3 in 
SW
d/d
 mice raised the interesting possibility that action of this transcription factor in the 
epithelium controls stromal proliferation by a paracrine mechanism. Previous studies reported 
that several members of the EGF family growth factors are expressed in the uterine 
epithelium and the EGF receptors (ERBB) are expressed in the uterine stroma during 
pregnancy (10,11). It was also reported that the expression of EGF-like factors in uterine 
luminal epithelium is drastically reduced in the Lif-null mice during implantation (41,42).  
However, the mechanisms that regulate the production of EGF-like growth factors 
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downstream of LIF in the preimplantation uterus, and most importantly, the precise uterine 
functions controlled by these factors remained unclear. We, therefore, considered the 
possibility that EGF ligands are potential paracrine mediators that function downstream of 
epithelial STAT3 to control stromal proliferation. Indeed, our studies revealed a dramatic 
reduction in the expression of several EGF family ligands in the epithelial cells of SW
d/d
 uteri 
compared to Stat3
f/f
 controls on day 5 of pregnancy (Figure 3.5A).  
The EGF family ligands exert their responses through the cell surface ERBB 
receptors. Stimulation of ERBBs by these growth factors leads to phosphorylation of specific 
tyrosine residues on the receptors, which in turn activate downstream signaling pathways 
(43). While ERBB1 is the major EGF receptor expressed in the uterine stroma, ERBB2 and 
ERBB3 are exclusively expressed in the luminal epithelium during the implantation window 
and ERBB4 is expressed in the sub-myometrial stroma and the myometrium (10,44). The 
signaling by EGF, HB-EGF, and AREG is mediated by either an ERBB1 homodimer or a 
heterodimer of ERBB1 and ERBB2-4 (43) We, therefore, determined the expression of 
ERBB1 in uteri on day 5 of pregnancy. We found it to be widely expressed in the stroma and 
the levels were comparable in uteri of Stat3
f/f
 and SW
d/d
 mice (Figure 3.5B, compare panels a 
and b). We also monitored the expression of the active, phosphorylated form of ERBB1 in 
uteri of Stat3
f/f
 and SW
d/d
 mice on day 5 of pregnancy. While a widespread expression of the 
phosphorylated ERBB1 was observed in the uterine stroma of Stat3
f/f
 mice on day 5 of 
pregnancy (Figure 3.5B, panel c), its levels were drastically reduced in the stromal cells of 
SW
d/d
 uteri (Figure 3.5B, panel d), indicating a marked reduction in stromal EGF signaling in 
the absence of epithelial Stat3. We also analyzed the expression of ERBB4 and phospho-
ERBB4, which are located in the submyometrial stroma. No significant differences in their 
levels were observed between Stat3
f/f
 and SW
d/d
 mice on day 5 of pregnancy (data not shown). 
We further examined whether LIF, acting upstream of STAT3 activation, is indeed the key 
factor controlling the production of the EGF family ligands in the epithelial cells. To test this 
possibility, we again used the delayed implantation model in which embryo attachment to the 
uterine epithelium is initiated in response to LIF. As shown in Figure 3.5C, administration of 
LIF to mice undergoing delayed implantation stimulated the synthesis of Egf, Hbegf, and 
Areg in uterine luminal epithelium. These results strongly supported our hypothesis that LIF-
mediated activation of luminal epithelial STAT3 drives the production of the EGF family 
ligands in this tissue. 
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Paracrine control of EGF receptor signaling is critical for stromal proliferation during 
decidualization 
To address whether the impaired production of the EGF family ligands in the luminal 
epithelium of SW
d/d
 mice was responsible for the observed defect in stromal cell proliferation 
during decidualization, we conducted an experiment in which these mutant mice were 
subjected to experimentally-induced decidualization with or without supplementation of the 
EGF family ligands. Since Egf, Hbegf, and Areg were collectively down regulated in uteri of 
SW
d/d
 mice, we administered a combination of these factors into the mutant uteri and then 
assessed their ability to rescue stromal proliferation. As shown in Fig. 3.6A, the stroma of 
vehicle-treated SW
d/d
 uteri showed significantly reduced proliferative activity (BrdU 
immunostaining) and expression of activated pERBB1 relative to control Stat3
f/f
 uteri 
(compare panels a and b, d and e). The levels of both BrdU-positive cells and pERBB1 were 
markedly elevated in the uterine stroma of SW
d/d
 mice treated with the mixture of EGF family 
ligands (Figure 3.6A, panels c and f). It is of interest to note that this treatment, which also 
increased the levels of pERBB1 in the luminal epithelium, did not trigger proliferation of 
these cells. Consistent with these observations, we found a marked upregulation of mRNAs 
corresponding to cell cycle regulators Ccne1 and Ccne2 in uterine stromal cells in response to 
stimulation by the EGF ligands (Figure 3.6B). Taken together, these results uncovered a 
paracrine regulatory mechanism in which the EGF family ligands, produced downstream of 
LIF-induced activation of STAT3 in luminal epithelial cells, trigger EGF receptor signaling 
in the stromal cells to critically control the proliferation of these cells during decidualization. 
 
DISCUSSION 
Previous studies showed that the production of LIF by uterine glands is obligatory for 
attachment of the embryo to uterine luminal epithelium (17). While it was reported that LIF 
induces phosphorylation of STAT3 in uterine epithelial cells during implantation, the 
downstream molecular pathways that mediate its effects on uterine functions remain largely 
unknown. Previous studies, using inhibitors of STAT3 pathway, have indicated a role of 
STAT3 in implantation (45,46). However, these studies did not provide any insight into the 
mechanisms via which STAT3 regulates uterine function. In this study, we investigated the 
molecular mechanisms via which the LIF-STAT3 signaling pathway controls uterine 
functions during implantation. Our studies provide unique insights into the pathways that 
operate downstream of STAT3 to control uterine epithelial remodelling and stromal 
proliferation and differentiation during implantation.  
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In mice, STAT3 is expressed in both uterine luminal epithelium and stroma during 
implantation (Fig. 3.1). This expression occurs in a biphasic pattern that overlaps with a 
similar biphasic expression of LIF, mainly in the uterine glandular epithelium (25,26). Since 
LIF receptors are primarily located in the luminal epithelium at the time of implantation, a 
detailed examination of the molecular events regulated by STAT3 would require a uterine 
epithelial-specific knockout of this gene. We, therefore, created SW
d/d
 mice in which 
conditional deletion of Stat3 occurred specifically in these cells. While ovarian function was 
unaltered and embryogenesis occurred normally in SW
d/d
 mice, the uteri of these animals 
displayed an inability to implant the embryos. Interestingly, many of the hallmarks of uterine 
receptivity remained unaffected in these mutant mice. For example, the circulating levels of 
estrogen and progesterone and the expression patterns of their cognate receptors in uterine 
compartments were indistinguishable between control and mutant mice (data not shown). The 
expression status of MUC-1, a glycocalyx protein, which is considered an important indicator 
of uterine receptivity, was examined (47,48). As the uterus achieves receptivity, MUC-1 
expression declines in normal luminal epithelium. We found that downregulation of epithelial 
MUC1 within the implantation window also occurred in SW
d/d
 mice (Figure 3.10A, panel a-
d). Additionally, other critical functional markers of uterine receptivity, such as Indian 
hedgehog (14,49)  and LIF exhibited unaltered expression in SW
d/d
 uteri compared to Stat3
f/f
 
uteri (Figures 3.10B and 3.10C). Although LIF expression was unaffected in the SW
d/d
 mice, 
this cytokine was unable to act on the uterine luminal epithelial cells in the absence of its 
downstream effector STAT3.  
Since uterine stromal Stat3 remained intact in SW
d/d
 mice (Fig 3.8), our study 
specifically addressed the uterine changes dictated by epithelial Stat3. In contrast, recent 
studies by Lee et al. (50) and Sun et al. (51) used conditional mutant mice, developed by 
crossing floxed Stat3 mice with PR-Cre mice, which resulted in Stat3 gene deletion in both 
epithelial and stromal compartments of the uterus. Loss of Stat3 in the stromal compartment 
apparently led to alterations in pathways in the stromal cells with consequent dysregulation of 
estrogen and progesterone signaling in the uterus as reported by these investigators. These 
effects are not observed when targeted deletion of Stat3 is carried out specifically in the 
epithelium, allowing us to uncover epithelium-specific roles of Stat3 and its paracrine effects 
on the stroma during implantation. 
Our study showed, for the first time, that STAT3 directs the cellular remodeling that 
alters the molecular organization of epithelial junctional complexes at the time of 
implantation. In the preimplantation phase, the integrity of the polarized luminal epithelium is 
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primarily maintained via adherent and tight junctions, which form a continuous seal of 
junctional complexes in the apical and basolateral regions of the epithelial cells (31). These 
junctions help maintain epithelial cell polarity by preventing the lateral diffusion of integral 
membrane proteins between the apical and basolateral surfaces. E-cadherin, a Ca2+-dependent 
transmembrane adhesion molecule, connects adjacent epithelial cells by linking their 
cytoskeletons via  and  catenins to maintain cell-cell adhesion and apical-basal polarity 
(31,52). In addition, components of tight junctions, such as the claudin family proteins, help 
establish a paracellular barrier between the epithelial cells and the intercellular space. They 
also participate in regulating the flow of diffusible molecules between adjacent polarized 
epithelial cells (53,54). The loss of apical-basolateral polarity of the luminal epithelial cells 
with consequent redistribution of plasma membrane proteins is long considered a pre-
requisite for successful implantation (55). It is believed that the uterus achieves receptivity by 
downregulating the tight and adherent junction complexes in the luminal epithelium. This 
loss of epithelial polarization allows the proper organization and presentation of cell surface 
adhesion molecules that allow interaction with the blastocyst trophectoderm initiating the 
process of implantation. Indeed, we observed a striking down regulation of several 
components of these junctional complexes in luminal epithelium as the uterus progressed 
from non-receptive (day 1) to receptive phase (day 5, morning) during normal pregnancy 
(Figure 3.11, compare panels a and c; panels d and f). 
It is evident that STAT3 signaling is critical for suppressing the expression of claudin-
1, -3 and -4 transcripts within the implantation window. It also down regulates the expression 
of α and β-catenin, which likely contributes to the redistribution of E-cadherin away from the 
lateral junctional complexes during implantation. These concerted changes in the junctional 
complexes, driven by STAT3 signaling, critically alters uterine epithelial phenotype by 
disrupting cell-cell linkages and altering cell polarity to allow the embryonic trophectoderm 
to attach to and invade through the epithelial cell layer into the underlying stromal tissue. 
Further support for this view comes from the observation that administration of exogenous 
LIF, which induces embryo attachment in progesterone-primed mice in a delayed 
implantation model, also specifically downregulates the same epithelial junctional proteins. 
Taken together, our results established that STAT3 acting downstream of LIF signaling 
dictates uterine epithelial reprogramming during implantation.  
The precise mechanisms by which STAT3 controls the expression of specific 
members of the claudin family and the  and  catenins in the uterine epithelium remain 
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unclear. Our preliminary analysis of the regulatory regions of claudin-1 gene indicated 
putative binding sites for STAT3, pointing to a possible direct mode of regulation of this gene 
by STAT3. Claudin-1 gene expression is also influenced by tyrosine kinase signaling in a 
variety of cancers (56,57). Therefore, it is possible that binding of LIF to the LIF receptor in 
the luminal epithelium, which activates JAK kinase-mediated tyrosine phosphorylation, 
contributes to the suppression of expression of a specific subset of claudin genes during 
implantation. The mechanism by which STAT3 promotes downregulation of E-cadherin from 
luminal epithelial junctional complexes at the time of implantation is also unclear. Previous 
studies indicated that, in certain tumour cells, STAT3 signaling induces downregulation of E-
cadherin mRNA via a pathway involving the transcription factor ZEB1 (58,59). We, 
however, did not observe a down regulation of E-cadherin mRNA in uterine epithelium of 
SW
d/d
 mice, indicating that a STAT3-ZEB1-dependent transcriptional repression of the E-
cadherin gene is unlikely to operate in these mutant uteri. Instead, we found that the levels of 
 and  catenin, which associate with E-cadherin in junctional complexes, are repressed by 
STAT3 signaling. These findings raise the possibility that the disappearance of E-cadherin 
from epithelial junctional complexes is partly due to the downregulation of  and  catenins 
in these complexes. Alternatively, signaling via STAT3 may alter E-cadherin post-
translationally, leading to its disappearance from the epithelial cell membrane. Further studies 
are needed to understand the exact mechanism by which STAT3 downstream of LIF 
signaling controls the expression and remodelling of the junctional protein complexes in the 
uterine epithelium. 
Another novel and important finding of this study is the discovery of an indispensable 
role of uterine epithelial STAT3 in regulation of stromal cell decidualization via a paracrine 
mechanism. Deletion of epithelial Stat3 in SW
d/d
 uteri without altering STAT3 expression in 
the stromal compartment impaired stromal cell decidualization in an experimentally-induced 
decidualization model, which does not require the presence of an embryo to induce the 
decidual response. Recent studies from our laboratory and elsewhere indicated a role for 
uterine stromal STAT3 in controlling human and mouse decidualization (50,51,60). In this 
paper, we report that uterine epithelial STAT3 signaling is also critical for this differentiation 
process. Specifically, we found that, in the absence of uterine epithelial STAT3, the stromal 
cells exhibit a significant reduction in their capacity to undergo proliferation in response to a 
decidual stimulus. These results suggested a role of epithelial STAT3 in promoting 
production and/or secretion of a paracrine factor(s) from the uterine epithelium, which in turn 
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induces stromal cell proliferation. Indeed, a marked reduction in the levels of a subset of EGF 
family growth factors was observed in the uterine epithelium of SW
d/d
 mice on day 5 of 
gestation compared to Stat3
f/f
 controls, indicating that these growth factors are likely 
downstream paracrine effectors generated by epithelial STAT3 signaling.  
The EGF family ligands induce cellular proliferation by binding to the ERBBs, which 
belong to a family of receptor tyrosine kinases (61). Upon ligand binding, the ERBB 
receptors dimerize, triggering autophosphorylation of several tyrosine residues in the C-
terminal domain. These phosphorylation events help activate several downstream pathways 
involved in cellular proliferation (62,63). ERBB1 is the predominant form of ERBB in the 
uterine stroma (41,44). Consistent with our hypothesis that the EGF family growth factors, 
synthesized in response to epithelial STAT3 signaling, control stromal proliferation during 
decidualization, we noted a marked reduction in the level of active, phosphorylated ERBB1 
in the uterine stroma of SW
d/d
 mice. The role of the EGF family growth factors as paracrine 
mediators of epithelial STAT3 was further confirmed when we administered a mixture of 
EGF family ligands to the uteri of SW
d/d
 mice during experimentally-induced decidualization. 
This treatment was effective in rescuing the uterine stromal proliferation defect in SW
d/d
 
mice.  This result strongly supported our view that STAT3-mediated production of EGFs in 
the luminal epithelium is critical for stromal proliferation. Our studies further demonstrated 
that administration of an implantation-inducing dose of LIF promotes the synthesis of several 
members of the EGF family in the luminal epithelium of mice undergoing delayed 
implantation. These results lend further support to our hypothesis that activation of STAT3 
downstream of LIF critically regulates epithelial-stromal crosstalk during implantation via a 
paracrine mechanism involving ERBB signaling. 
In summary, the SW
d/d
 mice, in which Stat3 is exclusively deleted in the luminal 
epithelium, provided a unique model to delineate the signaling pathways downstream of LIF, 
an essential regulator of uterine function during implantation (Figure 3.7). Our study revealed 
a novel mechanism by which STAT3 activation in luminal epithelium, in response to 
glandular LIF, regulates epithelial cell-cell junctions, polarity, and function during the 
receptive phase. It also promotes stromal proliferation at the time of decidualization via 
paracrine growth regulatory signals originating in the epithelium. Although this study focused 
on the role of STAT3 in uterine epithelium, further studies, utilizing both uterine epithelial- 
and stromal-specific knockouts of Stat3 will enable us to fully address the intricate and 
complex molecular mechanisms controlled by this critical transcription factor in the pre- and 
post-implantation uterus.   
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 MATERIALS AND METHODS 
Mice, hormone treatments, and tissue collection 
 All experiments involving mice were conducted in accordance with National 
Institutes of Health standards for the use and care of mice. The animal protocols were 
approved by the University of Illinois Institutional Animal Care and Use Committee. The 
Stat3 floxed (Stat3
f/f
) mice were kindly provided by Dr Shizuo Akira of Osaka University, 
Osaka, Japan, and Dr Hua Yu of City of Hope, Duarte, CA. Stat3
f/f
 mice were crossed with 
Wnt7a-Cre mice to generate SW
d/d
 mice. For mating studies, Stat3
f/f
 and SW
d/d
 female mice of 
C57BL/6 background were housed with wild-type C57BL/6 male mice (Charles Rivers). The 
presence of a vaginal plug after mating was designated as day 1 of pregnancy. 
In superovulation experiments, 7 to 8 week old female mice were injected 
intraperitoneally with 5 IU of pregnant mare serum gonadotrophin (PMSG) and 48 hours 
later with 5 IU of human chorionic gonadotropin (hCG). The mice were killed 16-18h post-
hCG administration, and oocytes were flushed from the oviducts and counted. 
To induce delayed implantation, mice were ovariectomized in the morning (0700-
0800 h) of day 4 of pregnancy and maintained by daily injections of P (2 mg per mouse) from 
days 5 to 7. To terminate delayed implantation and induce blastocyst attachment, the P-
primed delayed implanting mice were given 5 injections of LIF (1 ug, Santa Cruz) at 2 h 
intervals on the fourth day of the delay (day 8). Mice were killed at 24 h after last LIF 
injection and uteri were collected. 
Decidualization was experimentally induced in non-pregnant mice as described 
previously (24). Briefly, mice were first ovariectomized. Two weeks following ovariectomy, 
mice were injected with 100 ng of E in 0.1 ml of sesame oil for 3 consecutive days. This was 
followed by daily injections of 1 mg of P and 10 ng of E for 3 consecutive days. 
Decidualization was then initiated in one horn by injection of 50ul oil. The other horn was 
left unstimulated. The mice were treated with E+P for additionally post stimulation and then 
killed to collect the uterine tissue either 20 h post stimulus or 72 h post stimulus. For the 
rescue of proliferation during decidualization, 100 ul of vehicle (HBSS) or an EGF family 
cocktail, containing EGF (20ug, Sigma-Aldrich), HB-EGF (5ug, R&D systems), AREG 
(100ug, R&D systems), was added intraperitoneally every 2 h for 6 h prior to decidual 
stimulation. BrdU (100ul) was injected 2 h prior to collection and uteri were collected 20 h 
post stimulus.  
For analysis of gene expression during normal pregnancy, uteri were collected at 
different days of pregnancy for RNA isolation and IHC. One horn of the uterus was fixed in 
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10% formalin prior to IHC, and the other horn was flash frozen in liquid nitrogen prior to 
RNA isolation. 
 
Uterine epithelial and stromal cell isolation 
Uteri were obtained from pregnant mice on day 4 or day 5. With the aid of a 
dissecting microscope, each uterine horn was cut transversely into two equal segments. The 
tissues were then incubated in 10 ml of a solution of 0.5% bovine pancreatic trypsin (Cooper 
Biomedical, Malvern, PA) in Ca- and Mg-free PBS, pH 7.4. Tissues were first incubated at 
4ºC for 1 h and then at 37ºC for 40 min. After incubation, the uterine tissue was squeezed 
with forceps, dissociating the epithelium from the uterine pieces. The epithelial fragments in 
the supernatant were collected with a pipette; this procedure was repeated three or four times. 
The epithelial fragments were collected by centrifugation at 100 X g for 5 min. The resulting 
cell pellet was subjected to RNA isolation protocol. 
The remaining uterine tissue was incubated with 0.5g/L collagenase at 37ºC for 40 
min. After incubation, the tube was shaken vigorously and the supernatant was passed 
through a 70 um mesh to remove tissue debris. Stromal cells were collected by centrifugation 
at 1700 X g for 5 min.  
 
DNA microarray analysis 
Uterine epithelial cells were isolated from day 4 pregnant Stat3
f/f
 and SW
d/d
 mice and 
total RNA was prepared. The RNA was hybridized to Affymetrix mouse arrays (GeneChip 
Mouse Genome 430A 2.0 array) containing probes that represented ~14,000 known genes. 
They were processed and analyzed, according to the Affymetrix protocol. 
 
Real-time PCR analysis 
Uterine tissue was either homogenized or uterine epithelium was isolated and total 
RNA was extracted by using TRIZOL reagent, according to the manufacturer’s protocol. 
cDNA was prepared by standard protocols. The cDNA was amplified to quantify gene 
expression by real-time PCR, using gene-specific primers and SYBR Green (Applied 
Biosystems, Warringtom, UK). The expression level of Rplp0 (36B4) or Cytokeratin 18 
(Ck18) was used as the internal control. For each treatment, the mean Ct and standard 
deviation were calculated from individual Ct values obtained from three replicates of a 
sample. The normalized ΔCt in each sample was calculated as mean Ct of target gene 
subtracted by the mean Ct of internal control gene. ΔΔCt was then calculated as the 
difference between the ΔCt values of the control and treatment sample. The fold change of 
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gene expression in each sample relative to a control was computed as 2
- ΔΔCt
. The mean fold 
induction and standard errors were calculated from three or more independent experiments.  
 
Immunohistochemistry 
Formalin-fixed uterine pieces were processed for paraffin embedding. Cross sections 
(5um thickness) were mounted onto microscope slides (Fisher Scientific). For 
immunostaining, uterine sections were deparaffinized in xylene (three times for 5 min each), 
rehydrated through a graded series of treatment with ethanol (100%, 95%, 85%, and 70% for 
5 min each), and rinsed in tap water. For all samples, antigen retrieval was performed by 
boiling the sections in 0.01 M sodium citrate buffer (pH 6.0) for 20 min, followed by 
incubation at RT for 30 min. A 5% solution of normal donkey serum (Jackson 
Immunoresearch) in PBS was used as a blocking buffer. Sections were incubated with the 
following primary antibodies diluted in blocking solution (0.25% bovine serum albumin 
[BSA], 0.3% Triton X-100, sterile PBS) overnight at 4°C: Ki67 (BD Pharmingen), STAT3 – 
79D7 (Cell Signaling), pSTAT3-Y705 (Abcam), ERBB1 (Santa Cruz), pERBB1( Cell 
Signaling), E-cadherin (Santa Cruz), β-Catenin (Santa Cruz) CLDN-1 (Santa Cruz). The 
sections were washed and incubated with either biotinylated secondary antibodies (Jackson 
Immunoresearch Laboratories Inc.) or Cy3/Dylite conjugated secondary antibodies for 60 
min. For biotinylated samples this was followed by incubation with streptavidin-conjugated 
horseradish peroxidase (Histostain kit; Zymed Laboratories Inc.) for 45 min. Sections were 
stained with 3-amino-9-ethyl carbazole (AEC) solution (Zymed Laboratories Inc.) and 
counterstained with Mayer’s hematoxylin (Sigma). Stained sections were mounted in 
diazabicyclo (2, 2, 2) octane (DABCO), Tris-Cl (pH 8.5), and sterile double- distilled water. 
Immunofluroescence samples were mounted in Prolong GOLD with DAPI and cured for 24h 
before imaging. Negative controls included incubation with donkey serum and omission of 
the primary antibody for all samples.  
 
Image capture and quantitation of immunostaining 
  The images of immunohistochemical staining were captured by using a Leica 
(Nussloch, Germany) DM2500 light microscope fitted with a Qimaging Retiga 2000R 
camera (Qimaging, British Columbia, Canada). For counting, at least 5 to 6 individual 20x 
fields from each sample were captured. The numbers of positively stained uterine 
nuclei in each field were averaged and expressed as a percentage of the total number of these 
cells. Images were processed on ADOBE Photoshop version 8. The standard deviation was 
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determined for each averaged total. ANOVA single-factor analysis was conducted on the 
grouped means to determine statistical significance at a significance of a p value of < 0.01. 
Immunofluorescence imaging was performed on a LEICA 700 confocal microscope. These 
images were directly documented from the scope with minimal processing. 
 
Steroid hormone assay 
The serum P4 and E levels were measured by radioimmunoassay by the University of 
Virginia Center for Research in Reproduction Ligand Assay and Analysis Core. 
 
Statistical analysis 
Statistical analysis was performed by t-test or ANOVA. The values were expressed as 
mean ± SEM and considered significant if p < 0.05. To test data in some experiments a 
Bonferroni's Multiple Comparison Test was applied to compare multiple data points. 
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Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. STAT3 is expressed and activated in the preimplantation uterus. Real-time 
PCR was performed to monitor the expression of mRNAs corresponding to Stat3 in uterus on 
days 1 to 5 of gestation. The relative levels of gene expression on different days of pregnancy 
were determined by setting the expression level of Stat3 mRNA (A, Left panel) on day 1 of 
pregnancy at 1.0. Rplp0, encoding a ribosomal protein, was used to normalize the level of 
RNA. Uterine sections from day 1 to day 5 (a–e) of pregnancy were subjected to 
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immunohistochemical analysis using anti-pSTAT3 (B, Right panel) antibody. Panel f shows 
uterine sections from day 3 pregnant mice treated with non-immune IgG. L, G and S indicate 
luminal epithelium, glandular epithelium and stroma, respectively. 
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Figure 3.2 Deletion of Stat3 from uterine epithelium prevents attachment of embryo.  A. 
Embryo implantation sites were examined in Stat3
f/f 
and SW
d/d
 mice by the vascular 
permeability assay, which can be scored as distinct blue bands (black arrows) following an 
injection of Chicago blue dye on day 5 of pregnancy (D5, n = 5) of pregnancy. The graph 
represents the quantification of implantation sites in Stat3
f/f 
and SW
d/d
 mice on day 5 of 
pregnancy.  
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Figure 3.2 (cont.) B. Failure of embryo attachment in SW
d/d
 uteri. Histological analysis of 
uterine sections obtained from Stat3
f/f 
(a) and SW
d/d
 (b) mice on day 5 (n = 4) of pregnancy by 
Haematoxylin and Eosin staining. Note the intimate contact between embryo and luminal 
epithelium in Stat3
f/f 
mice and the free floating embryo in the uterine lumen of SW
d/d
 mice. L 
and E indicate luminal epithelium and embryo respectively. 
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Figure 3.3 STAT3 regulates junctional remodelling in uterine luminal epithelium. A. 
Real-time PCR was performed to analyze the expression of selected adherent and tight 
junction components in uterine epithelial cells isolated from uteri of Stat3
f/f 
and SW
d/d
 mice on 
day 4 of pregnancy. The level of Ck18 was used as internal control to normalize gene 
expression. The data are represented as the mean fold induction ± SEM *p<0.01, **p<0.001. 
B. Confocal images showing expression of E-cadherin (panels a and d, green) and β-catenin 
(panels b and e, red) in uterine epithelial cells of Stat3
f/f 
and SW
d/d
 mice on day 4 of 
pregnancy. Arrows indicate the co-localization of these proteins (panels c and f, orange, 
merge) in the intercellular lateral junctions in LE of SW
d/d
 mice while E-cadherin expression 
is seen only in apical tips in uterine luminal epithelial cells of Stat3
f/f
 mice. 
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Figure 3.3 (cont.) C. Confocal images of CLDN1 protein (panels b, c, e, and f, red) 
expression. Arrows indicate persistent CLDN1 expression in intercellular junctions in LE of 
SW
d/d
 uteri (panel f) on day 4 of pregnancy as opposed to overall down regulation in the LE 
in Stat3
f/f
 uteri (panel c).
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Figure 3.3(cont.) D. Confocal images showing rescue of implantation upon administration of LIF to progesterone-primed mice undergoing 
delayed implantation. LIF induces nuclear localization and phosphorylation of STAT3 (red) in LE cells at the implantation site (panel f, white 
arrows mark STAT3 phosphorylation), total STAT3 protein levels in the luminal epithelium remain unaltered between control and LIF treated 
uteri (compare panel a and e), though STAT3 expression is more pronounced in the nuclei of LIF treated animals (white arrows, co-localization 
with DAPI appears as purple). Note the absence of E-cadherin (green, compare panels c and g) and down regulation of CLDN-1 (red, compare 
E-cad/β-Cat/DAPI CLDN1-1/DAPI pSTAT3/DAPI 
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panels d and h) in the intercellular junctions of LE at the implantation site of LIF-treated mice, while the expression of these proteins is 
maintained in the control uteri (indicated by white arrows). L and E indicate luminal epithelium and embryo, respectively. Note that embryo 
shows staining of E-cadherin, -catenin and CLDN-1.  
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Figure 3.4 Ablation of uterine epithelial Stat3 leads to a defect in decidualization. A. 
SW
f/f
 and SW
d/d
 mice were subjected to experimentally-induced decidualization. The right 
horn (R) was stimulated, while the left horn (L) was left unstimulated. (a) Stat3
f/f
, 72 h after 
decidual stimulation. Robust decidualization was observed in the stimulated right horn. (b) 
SW
d/d
, 72 h after decidual stimulation. Minimal or no decidualization was observed in the 
stimulated right horn. B. Ratio of wet weight gain in right vs left horn. *p, 0.001 (t-test, n=5). 
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Figure 3.4 (cont.) C. Cell proliferation was measured by Ki67 immunostaining in uterine 
sections of SW
f/f
 and SW
d/d 
mice. (a) Stat3
f/f
, 20 h after decidual stimulation; (b) SW
d/d
, 20 h 
after decidual stimulation. (c)  Stat3
f/f
, day 5 of gestation (d) SW
d/d
, day 5 of gestation. D. 
Percentage of Ki67-positive cells in the stromal compartment of SW
f/f
 and SW
d/d 
mice, 20 h 
after decidual stimulation. The data represents average number of cells from multiple fields 
of multiple uterine sections.*p,0.01 (t-test, n=5).   
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Figure 3.4 (cont.) E. Stromal cells were isolated from uteri on day 5 of pregnancy and total 
RNA was prepared. Real-time PCR was performed to monitor the expression of mRNAs 
corresponding to the cell cycle genes Ccne1, Ccne2, and Cdkn1A. The data are represented as 
the mean fold induction ± SEM, *p < 0.01. F. Alkaline phosphatase activity was detected in 
the decidualized stroma. (a) sections of Stat3
f/f
 uteri (b) sections of SW
d/d 
uteri. Purple color 
indicates alkaline phosphatase activity. 
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Figure 3.5 Uterine epithelial STAT3 controls EGF receptor signaling in the stroma. A. 
Real-time PCR was performed to monitor the expression of EGF family growth factors in the 
uterine epithelia of Stat3
f/f 
and SW
d/d
 mice on day 5 of pregnancy. Epithelial cells were 
isolated from pregnant mice as described in the Materials and Methods and total RNA was 
prepared. Ck18, an epithelial marker, was used to normalize the level of RNA. The data are 
represented as the mean fold induction ± SEM, **p < 0.001, *p < 0.01. B. The levels of 
ERBB1 and pERBB1 were examined in the uterine sections of Stat3
f/f 
and SW
d/d
 mice on day 
5 of pregnancy by IHC. Black arrows indicate the presence of pERBB1, an activated form of 
the receptor in secondary decidual zone of SW
f/f
 mice ((panel c). This immunostaining was 
dramatically reduced in secondary decidual zone of SW
d/d
 mice (panel d). 
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Figure 3.5 (cont.) C. Mice undergoing delayed implantation were treated with or without 
LIF. The uteri were collected, epithelial cells were isolated. Total RNA was prepared from 
these cells and subjected to real time PCR to monitor the expression of transcripts 
corresponding to various members of the EGF family. LIF induces the expression of several 
EGF family members in uterine epithelium at 24 h post treatment. The data are represented as 
the mean fold induction ± SEM, **p < 0.001. 
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Figure 3.6 Paracrine control of EGF receptor signaling is critical for stromal 
proliferation during decidualization. A. Rescue of stromal cell proliferation defect in SW
d/d
 
mice upon administration of the EGF family ligands. Stat3
f/f
 and SW
d/d
 mice were subjected to 
experimentally induced decidualization with or without treatment with vehicle (HBSS) or a 
cocktail of the EGF family ligands EGF, HBEGF, and AREG. Sections of decidualized 
uterine horns at 20h post stimulus were analysed by IHC employing antibodies against BrdU 
and pERBB1. (A, d) Stat3
f/f
 mice treated with vehicle; (b, e) SW
d/d
 mice treated with vehicle; 
(c, f) SW
d/d
 mice treated with the EGF family ligands. BrdU immunostaining is strong in (a), 
reduced in (b), and restored in (c). pERBB1 immunostaining is strong in (d), absent in (e), 
and restored in (f). B. Real time PCR analysis of Ccne1 and Ccne2. Stromal cells were 
isolated from uteri of SW
d/d
 mice treated with vehicle or EGF cocktail. Total RNA was 
prepared from these cells and analysed by real time PCR. The data are represented as the 
mean fold induction ± SEM, *p < 0.01.  
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Figure 3.7 Conceptual model of epithelial STAT3 action in the mouse uterus during 
implantation. In the preimplantation uterus, LIF, secreted from the glands, acts via the LIF 
receptors on the luminal epithelium to activate epithelial STAT3 via a phosphorylation event. 
The activated STAT3 then functions as a downstream effector of LIF to repress critical 
components of adherent and tight junctional complexes in the luminal epithelium, such as E-
cadherin,  and -catenin, and a subset of Claudins. This remodelling of epithelial junctions 
is critical for altering cell polarity and promoting embryo attachment. Activated epithelial 
STAT3 also induces the expression of several members of the EGF family in the luminal 
epithelium. These growth factors function as paracrine mediators to promote stromal 
proliferation and differentiation, which are key events during early pregnancy. 
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Figure 3.8 Deletion of Stat3 gene in the uterine epithelium of SW
d/d
 mice. A. Total RNA 
was extracted from epithelial and stromal cells isolated from uteri of Stat3
f/f
 and SW
d/d
 mice 
on day 4 of pregnancy (n= 4) as described in the Materials and Methods and analyzed by 
real-time PCR. Relative levels of Stat3 mRNA expression in uterine epithelium and stroma of 
SW
d/d 
mice are compared to those of Stat3
f/f
 mice. The data are represented as the mean fold 
induction ± SEM, **p < 0.001. B.  Immunohistochemical analysis of total STAT3 protein 
expression in the uterine sections of Stat3
f/f
 (left panel) and SW
d/d
 mice (right panel) on day 4 
of pregnancy. Notice the absence of STAT3 expression in luminal and glandular epithelium 
of SW
d/d
   mice, white arrows. L, G and S indicates luminal epithelium, glandular epithelium 
and stroma respectively. 
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Figure 3.9 Ovarian functions and preimplantation events remain unaffected in SW
d/d
 
mice.  A. Age-matched prepubertal Stat3
f/f
 (n= 3) and SW
d/d
 mice (n= 4) were subjected to 
superovulation. The oocytes were recovered and counted at 18 h following hCG 
administration (values are mean ± SEM). B. Preimplantation embryos were recovered from 
uteri of Stat3
f/f
 (n= 6) and SW
d/d
 mice (n= 6) in the morning of day 4 of pregnancy, counted 
(values are mean ± SEM) and imaged. C & D: P and E levels in serum of Stat3
f/f
 (n= 4) and 
SW
d/d
 mice (n= 3) mice on day 4 of pregnancy. 
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Figure 3.10 Assessment of uterine receptivity markers in SW
d/d
 mice. A. 
Immunohistochemical analysis of MUC-1 protein expression in the uterine sections of Stat3
f/f
 
(left panel) and SW
d/d
 mice (right panel) on day 1 (a and b) and day 4 (c and d) of pregnancy. 
L indicates luminal epithelium. B, C. Expression of Ihh and Lif  mRNA in SW
d/d
 uteri. Real-
time PCR was performed to monitor the expression of Ihh and Lif in the uterine epithelium of 
Stat3
f/f
 and SW
d/d
 mice on day 4 of pregnancy. The level Ck18 was used as internal control to 
normalize gene expression. 
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Figure 3.11 Downregulation of epithelial junctional complexes during implantation. Immunohistochemical analysis and confocal imaging 
of E-cadherin/β-catenin (upper panel) and CLDN1 (lower panel) expression in the uterine sections of Stat3f/f mice on day 1 (a and d), day 4, 
morning (b and e) and day 5, morning (c and f) of pregnancy. Orange color represents merged E-cadherin (green) and β-catenin (red) signals, 
indicating co-localization of these proteins. White arrows point toward intercellular junctions and indicate changes in expression of junctional 
factors. L and E indicate luminal epithelium and embryo, respectively. 
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Ongoing/Future Studies 
Role of Endothelial PAS Domain Protein – 1 (EPAS-1) in                                                                        
Uterine Decidual Angiogenesis 
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ABSTRACT 
Estrogen (E) and Progesterone (P) acting through their cognate nuclear receptors 
ESR1 and PGR are master regulators of critical events during pregnancy. Their role in 
embryo implantation and subsequent stromal cell decidualization is well documented. 
Concomitant with decidualization, an extensive vascular network develops in the stromal 
compartment through a process known as angiogenesis that supports the development of the 
implanted embryo.  The role of E and P in this process remains unclear and the molecular 
mechanisms underlying steroid hormone control of uterine angiogenesis remain unknown. E 
can regulate uterine stromal cells differentiation and angiogenesis through one of its 
downstream target genes, Connexin-43 (Cx-43). Deletion of Cx-43 in uterine stromal cells 
resulted in down-regulation of hypoxia inducible pathway, including its master regulator 
Endothelial PAS Domain Protein – 1 (EPAS-1), a transcription factor known to promote 
angiogenesis in other tissues. EPAS-1 is widely expressed in uterine stromal cells during 
decidualization and is induced by E in the ovariectomized mouse model. To address the 
functional role of this protein, we used the Cre-Lox strategy to create conditional mutant 
mice in which Epas-1 Epas-1
d/d
). These transgenic 
mice are infertile and exhibit an implantation and angiogenesis defect. In this study we are 
trying to assess the molecular mechanism behind the angiogenic defect seen in Epas-1
d/d
. 
Preliminary findings indicate that Epas-1
 
promotes angiogenesis in the uterus by regulating 
the expression of pro-angiogenic factors like Vascular Endothelial Growth Factor – A (Vegf-
A), Sphingosine kinase-1 (Sphk-1) and Angiopoeitin-2 (Angpt-2). Further studies will reveal 
the exact mechanism of regulation of these factors by EPAS-1 and their role in uterine 
decidual angiogenesis.  
107 
 
INTRODUCTION 
Steroid hormones estrogen (E) and progesterone (P) orchestrate the structural and 
functional changes in the mammalian uterus during early stages of pregnancy that enable 
blastocyst attachment, initiating the process of implantation [1, 2]. In mouse and human, as 
the embryo invades the stromal compartment, the fibroblastic stromal cells undergo 
differentiation into a unique secretory tissue, termed decidua [3]. This transformation process, 
known as decidualization, is crucial for executing extensive tissue remodeling that ensures 
proper maternal-fetal interactions, leading to the establishment of pregnancy.  
Decidualization is also accompanied by the creation of an extensive vascular network 
within the stromal bed that supports embryonic and placental growth and maintains early 
pregnancy [4, 5].  During angiogenesis, new blood vessels are generated by the extension of 
pre-existing vessels into avascular space. This process involves the local degradation of the 
vascular basal membrane by proteases, proliferation and migration of endothelial cells and 
assembly of these cells into new vessels [6, 7]. In the female reproductive system, an active 
angiogenesis is required to support the cyclic remodeling of the uterus. Formation of these 
new maternal blood vessels in the stromal compartment at the time of embryonic 
implantation is critical for the establishment and maintenance of pregnancy [5, 8]. Although 
uterine angiogenesis is known to be influenced by the steroid hormones estrogen (E) and 
progesterone (P), the underlying molecular pathways remain poorly understood [9-11].  
Estrogen, acting via its nuclear receptors, exerts a profound influence on uterine functions 
during early pregnancy. However, only a few E-regulated genes important for implantation 
have been discovered so far. One such protein is, Cx-43 [12]. We have recently discovered a 
novel link between Cx-43 signaling and the expression of EPAS-1, within uterine stromal 
cells. EPAS-1 is a transcription factor that has been shown to be regulated by hypoxic 
conditions and regulates molecules essential for angiogenesis [13-15]. In order to study the 
functional role of Epas-1 we have created a conditional knockout of the Epas-1 gene which 
has Epas-1 knocked out in all cells expressing progesterone receptor (PGR). This conditional 
knockout mouse, termed Epas-1
d/d
, is infertile (data not shown) and exhibits an angiogenesis 
defect. Our preliminary findings indicate that Epas-1 regulates angiogenesis by regulating the 
expression of angiogenic factors such as Vegf-A, Sphk-1, and Angpt-2. Vegf-A, a potent 
endothelial cell mitogen that mediates rapid endothelial proliferation, is expressed in the 
decidua on morning of day 5 during the initiation of vascular permeability [16-18].  It is 
widely believed that VEGF-A plays a key role in angiogenesis within the uterine decidua 
during pregnancy. Similarly Sphk-1 has been shown to be of critical importance for fully 
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functional uterine decidual angiogenesis [19]. Future studies will reveal the exact mechanism 
of regulation of these angiogenic factors by Epas-1 and their role in uterine angiogenesis.  
 
RESULTS 
Downregulation of hypoxia induced angiogenic pathway in Cx-43
d/d
 mice uterine 
stromal cells 
We have previously shown that E acting through its downstream target Cx-43
 
controls 
crucial aspects of stromal decidualization and subsequent angiogenesis [12]. To gain insights 
into the mechanism underlying the angiogenesis defect observed in Cx-43
d/d 
mice, we isolated 
uterine stromal cells from Cx-43
f/f
 and Cx-43
d/d
 uteri on day 7 of pregnancy and performed 
gene expression profiling, using Affymetrix Mouse GeneChip arrays. Interestingly, our study 
revealed down-regulation of transcripts corresponding to genes involved in hypoxia induced 
angiogenic response in Cx-43
d/d 
mice uteri compared to Cx-43
f/f 
 control uteri (Figure 4.1A). 
The microarray data was validated by real-time PCR analysis. As shown in Figure 4.1B, we 
confirmed a marked down-regulation of mRNAs corresponding to Siah2, Epas-1, Sphk-1, Cx-
43 and Vegf-A in Cx-43
d/d 
mice uterine stromal cells. 
 
Genes involved in hypoxia mediated angiogenic response are expressed in uterine 
stromal cells during pregnancy    
Hypoxia-inducible factors (Epas-1, Epas-2, Epas-3) are central regulators of the 
cellular response to hypoxia [20]. Prolyl-hydroxylation of EPAS proteins by PHD enzymes is 
prerequisite for EPAS protein degradation [21, 22]. E3 ubiquitin ligase family member 
SIAH2 targets PHDs for degradation which results in increased stability of EPAS protein 
during hypoxia [23, 24]. Once stabilized EPAS protein can act on downstream targets to 
induce their expression and promote angiogenesis (Figure 4.2A). 
 In order to understand  the regulation of genes involved in hypoxia mediated 
signaling during  pregnancy we looked at the expression profile of Siah2, Epas-1, Sphk-1, 
and Vegf-A  on different days of pregnancy. Siah2 is expressed in the uterus in a progressive 
fashion; Siah2 levels are low on day 4-6 of pregnancy, its levels increase by day 7 and then 
remain high until day 10 of pregnancy (Fig. 4.2B). Levels of Epas-1 show a similar 
expression pattern to Siah2, with lower levels from D4-D6 followed by high expression 
through D7-D10 of pregnancy (Fig. 4.2C). Levels of Sphk1 increase in uterine stromal cells 
by D8 of pregnancy and remain high through D10 of pregnancy (Fig. 4.2D).  However, Vegf-
A  shows a biphasic pattern of expression with levels declining from D4-D6 of pregnancy, 
followed by high expression on D7 which subsequently declines to low levels by D10 of 
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pregnancy(Fig. 4.2E). This overlapping expression pattern of Siah2, Epas-1, Sphk-1 and 
Vegf-A indicates a regulatory network wherein SIAH2 inhibits the PHDs promoting the 
expression of EPAS-1 which in turn regulates the expression of angiogenic factors like Sphk-
1 and Vegf-A  in the uterine stromal cells to promote angiogenesis.  
 
Epas-1 is essential for uterine angiogenesis  
Epas-1
d/d 
mice are infertile and our preliminary analysis indicated that these mice 
exhibit an implantation defect (data not shown). Interestingly, uterine stromal cells in these 
mutant animals do undergo initial decidualization reaction and have comparable wet weight 
gain compared to Epas-1
f/f
 mice uteri. We proceeded by analyzing the angiogenic capacity of 
Epas-1 deficient uteri during pregnancy. When the uterine sections of pregnant Epas-1
f/f
 mice 
were immunostained using an antibody against platelet/endothelial cell adhesion molecule 
(PECAM), a marker of endothelial cells, they displayed a well-developed vascular network 
spanning the endometrial bed that surrounds the implanted embryo on day 7 of pregnancy 
(Figure 4.3, a). The PECAM immunostaining, however, was reduced drastically in uterine 
sections of Epas-1
d/d 
 mice on day 7, indicating that only a rudimentary vasculature formed in 
mutant uteri (Figure 4.3, compare panel a & b). 
This result indicated that Epas-1
d/d 
mice exhibit an angiogenesis defect during 
pregnancy. However, the embryos in Epas-1
d/d 
mice do not survive in utero beyond day 7 of 
pregnancy. Therefore, it was important to address whether Epas-1 controls uterine decidual 
angiogenesis independently of embryonic development.  non-pregnant mice were subjected 
to experimentally induced decidualization in which a mechanical perturbation of the steroid-
primed uteri triggers a decidual response in absence of the implanting embryo [25]. Uteri of 
ovariectomized Epas-1
f/f
 and Epas-1
d/d 
mice were prepared by treating these animals with a 
well-established regimen of E and P, and then decidualization was initiated in the left uterine 
horn by injecting 50ul oil while the right horn was left unstimulated. Immunohistochemical 
analysis of Epas-1
f/f
 and Epas-1
d/d 
uteri with a PECAM antibody revealed that the artificially 
stimulated Epas-1
f/f
 horn displayed an extensive endothelial cell network spanning the 
endometrial bed (Figure 4.3, c). By contrast, similarly treated uterine horns of Epas-1
d/d 
mice 
displayed drastically reduced PECAM staining, indicating that only a rudimentary 
vasculature was formed (Figure 4.3, d). These studies clearly indicate that even in the 
absence of the conceptus, EPAS-1 plays a crucial role in uterine decidual angiogenesis in the 
uterus. 
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Epas-1 regulates uterine decidual angiogenesis 
We next wanted to identify the downstream targets of EPAS-1 which play a role in 
uterine decidual angiogenesis. It is known that EPAS proteins regulate the expression of their 
downstream targets Vegf-A and Sphk-1 in order to promote angiogenesis in various tissue 
[26-29]. Additionally, Epas-1 has been shown to directly regulate the expression of Vegf-A 
by binding to its promoter in certain tissues [30]. Therefore, we analyzed the expression of 
these angiogenic factors in uterine stromal cells isolated from Epas-1
f/f
 and Epas-1
d/d 
mice. 
Uterine stromal cells were isolated from day 4 pregnant mice and subjected to in vitro 
decidualization protocol in the presence of E+P for 72h or 96h. As shown in figure 4.4A, the 
levels of angiogenic factors such as Vegf-A, Sphk-1, and Angpt-2 were markedly reduced in 
the stromal cells of mutant mice 96h post decidualization. Interestingly, Angpt-1, which 
antagonizes the action of Angpt-2 was upregulated. Prl8a2, a terminal differentiation marker, 
was also down-regulated in  Epas-1
d/d 
 stromal cells, indicating defective terminal 
differentiation (Figure 4.4A). These results suggested that the impaired angiogenesis 
observed in Epas-1
d/d 
mice uteri might be due to the lack of regulation of angiogenic factors 
by EPAS-1. In order to test if this downregulation of Vegf-A at the mRNA level translates 
into decreased protein expression, we checked the levels of VEGF-A protein in the same 
conditions by immunofluorescence and ELISA. As shown in figure 4.4B, the basal 
expression level of VEGF-A was similar between Epas-1
f/f
 and Epas-1
d/d 
mice uterine stromal 
cells (compare panels a and b), but there was dramatic decrease of VEGF-A protein in the 
mutant stromal cells when compared to Epas-1
f/f
 at 96h post decidualization (Figure 4.4B, 
compare panels c and d). VEGF-A is a secreted protein and hence it can be detected in the 
surrounding medium by ELISA. As shown in figure 4.4C, levels of VEGF-A protein were 
significantly reduced in mutant stromal cells when compared to control at 72h post 
decidualization, and declined further at 96h post decidualization. These results clearly show 
that EPAS-1 regulates the expression of angiogenic factors in the uterine stromal cells during 
pregnancy to promote angiogenesis. 
 
DISCUSSION 
Angiogenesis is a physiological mechanism leading to growth of new blood vessels 
from pre‐formed ones. The endothelium goes through several different processes including 
cell proliferation, cell migration, tube formation, endothelium repair, etc. A number of 
publications have described a link between impaired angiogenesis in the uterus with 
pregnancy related diseases such as pre-eclamptic pregnancies, gestational diabetes, and 
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intrauterine growth restriction. [5, 31, 32]. According to these studies, faulty angiogenesis is 
due to  compromised secretion and activity of pro‐angiogenic factors such as VEGF, SPHK-
1, ANGPT-2, interleukin 8 (IL‐8), as well as anti‐angiogenic factors such as soluble receptor 
of VEGF (sFlt‐1), ANGPT-1, etc. [16, 18, 33].  
E, acting through its nuclear receptor ESR1, is known to play a critical role during 
implantation, but its role in uterine angiogenesis remains unknown. Our group has recently 
identified a novel link between E signaling and angiogenesis in the uterus. Cx-43 and Epas-1 
are downstream targets of E which mediate its effects on uterine angiogenesis. Studies 
involving Cx-43
d/d
 mice revealed a link between gap junction signaling and hypoxia induced 
signaling which leads to angiogenesis (Figure 4.4 A, B). The complementary expression 
profile of genes involved in regulation of hypoxia mediated signaling and its downstream 
targets in the uterus suggested active signaling. However, it is known that EPAS proteins 
turnover is regulated not only at transcriptional level, but also at a post translational level by 
an intricate mechanism which involves Siah2’s inhibition of PHD enzymes thereby limiting 
EPAS proteins proteasomal degradation during hypoxia [34, 35]. Therefore, in order to 
further understand this regulatory mechanism operational during hypoxia we are also 
studying the protein expression profile of these genes involved in hypoxia mediated 
responses during pregnancy.  
In order to understand the molecular basis of the effects of hypoxia mediated 
signaling in the uterus we generated Epas-1
d/d
 animals in which Epas-1 has been knocked out 
of all uterine cells expressing PGR. Even though Epas-1
d/d
 mice ovulate, they are infertile. 
Surprisingly, we found that embryos attach to Epas-1
d/d
 luminal epithelium but are unable to 
penetrate through the luminal epithelial cells (data not shown). It is remarkable that Epas-1
d/d
 
stromal cells are able to begin decidualization even though the embryo does not come into 
contact with stromal cells. Stromal cell expression of alkaline phosphatase activity is 
unaltered in the Epas-1
d/d
 uterus and uterine wet weight gain is statistically the same as in   
Epas-1
f/f
 mice 72 hours after artificial decidual stimulus. However, Epas-1
d/d
 decidual cells 
do not express PRP, a classic decidualization marker which is induced on day 7 of pregnancy 
(data not shown). This indicates that Epas-1
d/d
 stromal cells are unable to fully differentiate 
and may never reach a terminal differentiated status.  
We began to study Epas-1
d/d
 function in the uterus with the hypothesis that this 
transcription factor mediates angiogenesis in the uterus. As marked by PECAM staining, we 
can see that angiogenesis is impaired in Epas-1
d/d
 mice on day 7 of pregnancy and during 
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experimentally induced decidualization. It will be imperative to identify the downstream 
molecular pathways of Epas-1
 
during stromal cell decidualization. Initial results suggest that 
EPAS-1 regulates the expression of proangiogenic molecules in the uterus that contribute 
positively to uterine angiogenesis. Further studies into the exact mechanism of action of 
EPAS-1 and its regulation of Vegf-A and Sphk-1 will enable us to decipher the signaling 
mechanism underlying hypoxia induced uterine decidual angiogenesis. 
 
MATERIALS AND METHODS 
Animals and Tissue Collection 
All animals were maintained in University of Illinois animal facilities. The health of 
the animals was monitored by Division of Animal Resources veterinarians. All procedures 
involving the use of animals were approved by the University IACUC committee. Epas-1 
floxed mice were obtained from Jax Laboratories. Transgenic female mice were mated to 
mature C57 wild-type males. The copulatory plug indicates day 1 of pregnancy. Female mice 
were then subsequently euthanized by carbon dioxide overdose on different days of 
pregnancy. The uterus was collected and either fixed in 10% buffered formalin for paraffin 
blocks, frozen or used to isolate stromal cells. 
 
Artificial Decidualization 
Decidualization was artificially induced as previously described [12]. Mice were 
ovariectomized and rested for 2 weeks to remove circulating hormones. Animals then were 
injected with 100ng estrogen in 0.1ml corn oil s.c. daily for three days and then rested for two 
days. Following rest, mice were injected with E (10ng) and P (2mg) in 0.1ml corn oil for 
three days. On the third day of E+P injection mice were anesthetized and corn oil was 
injected into 1 uterine horn. Mice were then injected daily with E+P until mice were 
euthanized.  
 
Uterine Stromal Cell Isolation 
Uterine stromal cells were isolated as previously described [12]. Briefly, uteri were 
removed from mice after euthanasia with carbon dioxide. The uterus was cut open and 
digested with 6 g/liter dispase (Invitrogen) and 25g/liter pancreatin for 1hr at room 
temperature. The enzymes were quenched with 10% FBS and cells were washed with Hanks 
balanced salt solution (HBSS). Cells were then incubated in 0.5 g/liter collagenase in HBSS 
for 1hr at 37
0
C. After incubation the tubes were vortexed for 10-12 s until the supernatant 
became turbid with dispersed cells. The contents of the tube were then passed through a 80-
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μm gauze filter (Millipore). Cells were resuspended in Dulbeccos modified Eagle's medium-
F12 medium (DMEM-F12; with 100 unit/liter penicillin, 0.1 g/liter streptomycin, 1.25 
mg/liter fungizone) containing 10% heat-inactivated fetal calf serum and live cells were 
assessed by trypan blue staining using a hemocytometer. 
 
Immunofluorescence  
Immunofluorescence was carried out as previously described [36]. Frozen sections or 
cells in a four well chamber slide were used. Briefly, uterine sections/cells were fixed in 10% 
formaldehyde for 10 minutes followed by 3 x (1x PBS) washes. These were then blocked for 
1 h at room temperature with serum. Sections were then incubated with primary antibodies 
against PECAM (BD), VEGF-A (Santa Cruz) overnight at 4
0
C. Sections were then incubated 
with secondary antibodies conjugated to Cy3 at room temperature followed by coversliping 
with Prolong Gold reagent containing DAPI. 
 
Quantitative PCR and RNA Isolation 
RNA was isolated from tissues or cells using trizol followed by RNA cleanup kit 
(Qiagen). RNA was converted to cDNA using a kit (Applied Biosystems). Oligonucleoties 
specific for genes of interest were developed. QPCR reaction was carried out using SYBR-
Green master mix (Applied Biosystems) on either 7000 or 7500 Applied Biosystems Real-
time PCR machines. 
 
Microarray Analysis 
Uterine stromal cells were isolated from D7 pregnant Cx-43
f/f 
and Cx-43
d/d 
 mice. 
Messenger RNA was isolated from cells using trizol and purified using a Qiagen kit. 
Messenger RNA was submitted to the Keck Biotechnology Center at UIUC and hybridization 
on Affymetrix chips was performed. Data were analyzed using Panther and Ingenuity 
Pathway Analysis software.  
 
ELISA – VEGFA 
Secretion of mouse VEGF by uterine stromal cells was detected by Quantikine mouse 
VEGF immunoassay (R&D, Minneapolis, MN) following the manufacturer’s instructions. 
The detection limit for VEGF-A was 3 ng/liter. 
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Figure 4.1 Downregulation of hypoxia induced angiogenic pathway  in  Cx-43
d/d
 mice 
uterine stromal cells. A. Tabular representation of selected data obtained from microarray 
analysis of RNA obtained from uterine stromal cells isolated from uteri of Cx43
f/f 
and Cx43
d/d
 
mice on day 7 of pregnancy.  B. Real-time PCR was performed to analyze the expression of 
selected hypoxia mediated pathway genes and Cx43 in uterine stromal cells isolated from 
uteri of Cx43
f/f 
and Cx43
d/d
 mice on day 8 of pregnancy. The level of Rplp0 was used as 
internal control to normalize gene expression. The data are represented as the mean fold 
induction ± SEM *p<0.01, **p<0.001.           
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Figure 4.2 Genes involved in hypoxia mediated angiogenic response are expressed in 
uterine stromal cells during pregnancy. A. Hypothetical model of hypoxia induced 
cellular signaling in mouse uterine stromal cells during pregnancy Real-time PCR was 
performed to monitor the expression of mRNAs corresponding to Siah2 (B), Epas-1 (C), 
in uterus on days 4 to 10 of gestation. The relative levels of gene expression on different 
days of pregnancy were determined by setting the expression level of specific mRNA on 
day 4 of pregnancy at 1.0. Rplp0, encoding a ribosomal protein, was used to normalize 
the level of RNA.  
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Figure 4.2 (cont.) Real-time PCR was performed to monitor the expression of mRNAs 
corresponding to Sphk-1(D) and Vegf-A (E) in uterus on days 4 to 10 of gestation. The 
relative levels of gene expression on different days of pregnancy were determined by setting 
the expression level of specific mRNA on day 4 of pregnancy at 1.0. Rplp0, encoding a 
ribosomal protein, was used to normalize the level of RNA.  
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Fig. 4.3 Epas-1 is essential for uterine angiogenesis. Immunofluorescence staining for 
PECAM (red) in uterine sections. Uterine sections of Epas-1
f/f
 (a, c) and Epas-1
d/d
 (b, d) mice 
on day 7 of pregnancy (a, b) and 72h post decidual stimulus (c, d) are shown 
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Fig. 4.4 Epas-1 regulates uterine decidual angiogenesis. A. Real-time PCR was performed 
to monitor the expression of mRNAs corresponding to various angiogenic and decidual 
factors in isolated stromal cells from D4 pregnant Epas-1
f/f
 and Epas-1
d/d
 mice uteri treated 
with E+P and cultured for 96h. Rplp0, was used as internal control to normalize gene 
expression. 
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Figure 4.4 (cont.) B. Immunofluorescence staining for VEGF-A and Phalloidin in in vitro 
decidualized uterine stromal cell. Epas-1
f/f
 (a,c) and Epas-1
d/d
 (b,d) cells, basal (a,b) and 96h 
after in vitro decidualization (c,d) are shown.   
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Figure 4.4 (cont.) C. Epas-1
f/f
 and Epas-1
d/d
 uterine stromal cells were grown for 72h and 
96h in the presence of E+P. The VEGF-A in supernatant was measured in duplicate by 
ELISA. 
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During early pregnancy, the maternal steroid hormones E and P promote blastocyst 
implantation and uterine stromal cell decidualization. E and P act on their target cells in the 
uterus via their receptors ESR1 and PGR. Global receptor knockout studies in mice have 
firmly established the importance of ESR1 and PGR during implantation. Although these 
studies prove that steroid mediated signaling is indispensable for successful pregnancy, they 
do not shed light on the underlying mechanism of action of these hormones. Also, these 
global hormone receptor knockout mice lack hormone mediated signaling in the whole 
uterus, which makes it impossible to understand the role of hormone mediated signaling in a 
uterine compartment specific fashion.  
The aim of my thesis work was to investigate the compartmental specific role of 
ESR1 during pregnancy, the underlying mechanism of action, and the process of epithelial-
mesenchymal interactions. To this end, we used a conditional knockout of ESR1 in which 
ESR1 was deleted solely from the epithelial compartment of the uterus. This deletion would 
allow us to investigate the loss of ESR1 in the epithelium, the stromal function of ESR1 
remained unaffected. Using this mouse model, we first investigated whether the epithelial 
function was maintained in these animals. Loss of epithelial ESR1 did not affect E mediated 
epithelial proliferation, indicating there is a paracrine signaling mechanism which originates 
from the stroma that regulates epithelial proliferation. These results align with our previous 
observation in Hand2-null mice, in which uterine stromal FGF’s drive uterine epithelial 
proliferation. Hand2 is a transcription factor under the control of PGR.  Hand2 blocks this 
proliferation by inhibiting FGF secretion during the receptive phase. We next investigated 
whether the loss of epithelial ESR1 affects uterine stromal decidualization. This 
decidualization is one of the prerequisites for successful implantation which entails 
differentiation of endometrial stromal cells into a unique secretory tissue, known as the 
decidua. We discovered that a loss of epithelial ESR1 results in a lack of stromal cell 
decidualization. Further studies indicated that E acting on glandular ESR1 promotes the 
secretion of the cytokine LIF, which is responsible for initiating the downstream signaling 
pathway leading to decidualization. We have shown that LIF, acting through its receptor on 
the epithelial cells, activates the MAPK pathway to induce the transcription of a well-known 
target of P signaling and a promoter of decidualization, IHH. IHH then acts in a paracrine 
manner on the stromal cells to promote their decidualization. This study elucidated a novel 
functional link between E and P signaling in the uterus during pregnancy. We have shown 
that during early pregnancy LIF and P act in concert to induce the expression of Ihh which 
then aids in stromal cell proliferation and differentiation leading to successful pregnancy.  
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This work identified LIF as a downstream target of glandular epithelial ESR1, which 
aids in stromal cell decidualization by acting through the MAPK pathway in the luminal 
epithelium around D2-D3 of pregnancy. It is known that during the receptive phase there is a 
second surge in expression of Lif around day 4.5 of pregnancy. At this point LIF binds to its 
receptor on the luminal epithelium and activates the JAK-STAT3 pathway to promote uterine 
receptivity. There is limited knowledge of the genes regulated by the LIF-JAK/STAT3 
pathway which makes the uterus receptive to the incoming embryo. In order to understand 
LIF mediated signaling through the JAK-STAT3 pathway we generated and studied an 
epithelial knockout of STAT3.  Interestingly, loss of epithelial STAT3 renders the uterus 
non-receptive to blastocyst implantation. We first assessed the effect of loss of epithelial 
STAT3 on uterine epithelial function during pregnancy. Our studies revealed that STAT3 
negatively regulates cell-cell connections in the epithelium by regulating the expression of a 
set of junctional adhesion complex proteins, catenins and claudins.  This was the first time 
that STAT3 was shown to direct the cellular remodelling that alters the molecular 
organization of epithelial junctional complexes at the time of implantation. Another novel 
and important finding of this study was the discovery of the indispensable role of uterine 
epithelial STAT3 in regulation of stromal cell decidualization via a paracrine mechanism. We 
found that loss of epithelial STAT3 inhibits the expression EGF family members from the 
luminal epithelium. These EGFs act in a paracrine manner through their cognate receptors on 
the stromal cells to promote proliferation and differentiation. Further studies will reveal the 
nature of regulation of junctional adhesion proteins and EGF family members by STAT3.   
Together, these studies shed light on complex and intricate signaling mechanisms 
driven by epithelial-stromal interactions at play in the uterus during early pregnancy. Our 
data reveal that the proliferative response of the uterine epithelium in response to E is 
independent of epithelial ESR1, and in fact is stimulated by growth factors released from the 
stroma. During the receptivity phase E acting through ESR1 promotes the secretion of LIF, 
which then activates the JAK/STAT3 pathway in the luminal epithelium to trigger the 
cellular remodeling that makes the epithelium receptive to the implanting embryo (Fig 5.1). 
One of the most interesting discoveries that emerged from these projects is that epithelial 
ESR1 is indispensable for uterine stromal cell decidualization. During early pregnancy E 
acting through glandular ESR1 promotes the secretion of LIF which along with P acts on the 
luminal epithelial cell through the MAPK pathway and induces the expression of Ihh. IHH 
binds to its receptor PTCH1 on the stromal cell and promotes decidualization by inducing the 
expression of molecules like NR2F2. Around day 4.5 of pregnancy, E once again promotes 
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the secretion of LIF which now acts on the luminal epithelial cell via the JAK-STAT3 
pathway. This induces the expression of EGF family members, which are secreted into the 
stroma and help in stromal proliferation and differentiation (Fig 5.2).  
The current challenge is to understand how these studies in mice translate into human 
uterine function. A recent study in our lab has shown the importance of ESR1, as well as 
STAT3 in human endometrial stromal decidualization. It would be interesting to determine if 
the dysregulation of these factors affects fertility and other reproductive pathologies, such as 
endometriosis and endometrial cancer. Impaired stromal-epithelial interactions may also 
contribute to endometrial hyperplasia, a precursor to endometrial cancer which is associated 
with unregulated E signaling.  Treatment regimens for endometrial hyperplasia often include 
progestin therapy to inhibit E mediated proliferation.  Recently, Jones et al. identified 
HAND2 as the most commonly hypermethylated and silenced gene in endometrial 
hyperplasia and cancer and the degree of HAND2 methylation was positively correlated with 
the severity of hyperplasia. It is possible that molecules like LIF, IHH and STAT3, which we 
have discovered play an important role in epithelial stromal interaction, may be dysregulated 
in different reproductive pathologies. Further exploration of these complex signaling 
mechanisms regulating epithelial stromal interactions in the uterus during pregnancy, and 
their dysregulation in certain reproductive pathologies would help in developing a targeted 
approach in treating infertility as well as certain endocrine disorders.  
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Figure 5.1 Prior to implantation, E, acting through ESR1 in the stroma (pink), drives 
epithelial (purple) proliferation through the secretion of paracrine acting FGFs.  During the 
periimplantation period, P, acting on PGR in the stroma, promotes the expression of HAND2.  
HAND2 inhibits expression of FGFs and blocks E induced epithelial proliferation.  E induced 
LIF in the glandular epithelium (blue) acts in a paracrine manner on the luminal epithelium 
(purple) to activate the JAK/STAT pathway to mediate a shift in junctional integrity required 
for implantation.  Activation of LIF activation of JAK/STAT also promotes proliferation of 
the stroma (pink) via expression and secretion of EGFs from the luminal epithelium.  Dashed 
lines represent indirect events.  E, estrogen; ESR1, E receptor; FGF, fibroblast growth factor; 
FGFR, FGF receptor; ERK1/2, extracellular signal regulated kinase1/2;  P, progesterone; 
PGR, P receptor; HAND2,  heart and neural crest derivatives expressed transcript 2, LIF, 
leukemia inhibitory factor; LIFR, LIF receptor; JAK/STAT3, Janus kinase/signal transducers 
and activators of transcription 3; EGF, epidermal growth factor; EGFR, EGF receptor. 
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Figure 5.2 In the preimplantation uterus around day 1-2 of pregnancy, E acting through its 
receptor ESR1 induces Lif production in the glands. LIF secreted from the glands, acts via the 
LIF receptors on the luminal epithelium and activates ERK signaling synergistically with P 
which acts through its receptor PGR. The JAK-STAT3 pathway is not activated by LIF in the 
luminal epithelial cells at this time. Activated MAPK then functions as a downstream effector 
of LIF and P to induce the expression of Ihh in the luminal epithelium. IHH secreted from the 
luminal epithelium activates the IHH-PTCH1-NR2F2 signaling cascade in the uterine stromal 
cells (pink). Around day 4-4.5 of pregnancy a second wave of LIF production activates 
JAK/STAT signaling in the epithelium. This promotes proliferation of the stroma via 
expression and secretion of EGFs from the luminal epithelium.  Dashed lines represent 
indirect events.  E, estrogen; ESR1, E receptor;  LIF, leukemia inhibitory factor; LIFR, LIF 
receptor; MAPK, MAP kinase; IHH, indian hedgehog; PTCH1, patch-1; NR2F2, Nuclear 
Receptor Subfamily 2, Group F, Member 2; JAK/STAT3, Janus kinase/signal transducers and 
activators of transcription 3; EGF, epidermal growth factor; EGFR, EGF receptor. These 
chain of signaling events help promote stromal proliferation and differentiation, which are 
key events during early pregnancy. 
